<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>European Journal of Nuclear Medicine and Molecular Imaging via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'European Journal of Nuclear Medicine and Molecular Imaging' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=European+Journal+of+Nuclear+Medicine+and+Molecular+Imaging&t=European+Journal+of+Nuclear+Medicine+and+Molecular+Imaging&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 03:37:31 +0100</lastBuildDate>
        <item>
            <title>[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH</title>
            <link>http://www.medworm.com/index.php?rid=5669829&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa2mq5l4l787l1859%2F</link>
            <description>Content Type Journal ArticleCategory Image of the MonthPages 1-2DOI 10.1007/s00259-012-2069-0Authors
		A. Afshar-Oromieh, Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, GermanyU. Haberkorn, Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, GermanyM. Eder, Department of Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, GermanyM. Eisenhut, Department of Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, GermanyCM. Zechmann, Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669829</comments>
            <pubDate>Mon, 06 Feb 2012 19:37:21 +0100</pubDate>
            <guid isPermaLink="false">5669829</guid>        </item>
        <item>
            <title>Adverse events in nuclear medicine – cause for concern?</title>
            <link>http://www.medworm.com/index.php?rid=5669830&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh140961122k52015%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-4DOI 10.1007/s00259-012-2071-6Authors
		B. Hesse, Department of Clinical Physiology, Nuclear Medicine &amp; PET, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100 Copenhagen, DenmarkN. Vinberg, The Isotope Agency, Capital Region Pharmacy, Herlev, DenmarkA. K. Berthelsen, Department of Clinical Physiology, Nuclear Medicine &amp; PET, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100 Copenhagen, DenmarkJ. R. Ballinger, Department of Nuclear Medicine, Guy’s and St Thomas’ Hospital, London, UK
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669830</comments>
            <pubDate>Mon, 06 Feb 2012 19:37:19 +0100</pubDate>
            <guid isPermaLink="false">5669830</guid>        </item>
        <item>
            <title>Comment on Reyes et al.: Myocardial perfusion scintigraphy in Europe 2007: a survey of the European Council of Nuclear Cardiology</title>
            <link>http://www.medworm.com/index.php?rid=5669832&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk637329263251282%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-1DOI 10.1007/s00259-012-2072-5Authors
		Ali Gholamrezanezhad, Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669832</comments>
            <pubDate>Fri, 03 Feb 2012 17:51:36 +0100</pubDate>
            <guid isPermaLink="false">5669832</guid>        </item>
        <item>
            <title>18F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas</title>
            <link>http://www.medworm.com/index.php?rid=5669831&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F40277403mt7jxtj6%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;These preliminary data suggest that FMISO PET may distinguish GBM from lower grade gliomas.
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-2037-0Authors
		Kenji Hirata, Department of Nuclear Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-Ku, Sapporo, Hokkaido 060-8638, JapanShunsuke Terasaka, Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanTohru Shiga, Department of Nuclear Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-Ku, Sapporo, Hokkaido 060-8638, JapanNaoya Hattori, Department of Molecular Imaging, Graduate School of Medicine, Hokkaido University, Sapporo, JapanKeiichi Magota, Department of Radiology, Ho...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669831</comments>
            <pubDate>Fri, 03 Feb 2012 17:51:36 +0100</pubDate>
            <guid isPermaLink="false">5669831</guid>        </item>
        <item>
            <title>Measuring glomerular filtration rate from plasma clearance of 51Cr-EDTA: quality assurance</title>
            <link>http://www.medworm.com/index.php?rid=5661511&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv0j4447237863386%2F</link>
            <description>Content Type Journal ArticleCategory Editorial CommentaryPages 1-2DOI 10.1007/s00259-012-2073-4Authors
		Michael Rehling, Department of Clinical Physiology and Nuclear Medicine, Århus University Hospital, Skejby, DK-8200 Århus N, Denmark
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661511</comments>
            <pubDate>Fri, 03 Feb 2012 07:19:31 +0100</pubDate>
            <guid isPermaLink="false">5661511</guid>        </item>
        <item>
            <title>Biodistribution and dosimetry of 123I-mZIENT: a novel ligand for imaging serotonin transporters</title>
            <link>http://www.medworm.com/index.php?rid=5661513&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb3437112t04807p5%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;
 123I-mZIENT may be a promising radioligand for imaging the serotonin transporters in humans with acceptable dosimetry.
 
 
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-6DOI 10.1007/s00259-011-2056-xAuthors
		Alice Nicol, Department of Nuclear Medicine, Southern General Hospital, NHS Greater Glasgow &amp; Clyde, 1345 Govan Rd, Glasgow, G51 4TF UKRajeev Krishnadas, Sackler Institute of Psychobiological Research, University of Glasgow, Glasgow, UKSue Champion, Institute of Neuroscience and Psychology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UKGilles Tamagnan, Institute for Neurodegenerative Disorders, New Haven, CT, USAJeffrey S. Stehouwer, Department of Radiology and Imaging Sciences, Emory University, Atla...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661513</comments>
            <pubDate>Fri, 03 Feb 2012 07:19:30 +0100</pubDate>
            <guid isPermaLink="false">5661513</guid>        </item>
        <item>
            <title>Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates</title>
            <link>http://www.medworm.com/index.php?rid=5661512&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4367336481k47086%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Pretargeting prostate cancer with Bom-bsCx or Bom-bsFCx enabled fast delivery of high specific radioactivity 111In- or 99mTc-labeled polymer-drug conjugates resulting in visualization of lesions smaller than 1–2&amp;nbsp;mm in diameter within 3&amp;nbsp;h.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-16DOI 10.1007/s00259-011-2050-3Authors
		Vishwesh Patil, Department of Pharmaceutical Sciences, Northeastern University, School of Pharmacy, Mugar Bldg, Rm 205, 360 Huntington Avenue, Boston, MA 02115, USAKeyur Gada, Department of Pharmaceutical Sciences, Northeastern University, School of Pharmacy, Mugar Bldg, Rm 205, 360 Huntington Avenue, Boston, MA 02115, USARajiv Panwar, Department of Pharmaceutical Sciences, Northeastern University, School of Phar...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661512</comments>
            <pubDate>Fri, 03 Feb 2012 07:19:30 +0100</pubDate>
            <guid isPermaLink="false">5661512</guid>        </item>
        <item>
            <title>Correction of an important typographical error in the European Association of Nuclear Medicine (EANM) guidelines</title>
            <link>http://www.medworm.com/index.php?rid=5661514&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg214702431211350%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-1DOI 10.1007/s00259-012-2066-3Authors
		Elizabeth Anne Anderson, Medicines Information Service, Department of Pharmacy, Westmead Hospital, Westmead, Sydney, NSW 2145, Australia
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661514</comments>
            <pubDate>Thu, 02 Feb 2012 18:13:16 +0100</pubDate>
            <guid isPermaLink="false">5661514</guid>        </item>
        <item>
            <title>Dynamic FDG PET for assessing early effects of cerebral hypoxia and resuscitation in new-born pigs</title>
            <link>http://www.medworm.com/index.php?rid=5661515&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7846554165720j44%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Dynamic FDG PET detected decreased cerebral glucose metabolism early after perinatal hypoxia in piglets. The decrease in CMRgl may indicate early changes of mild cerebral hypoxia–ischaemia. No significant effect of hyperoxic resuscitation on the degree
 of hypometabolism was found in this early phase after hypoxia. Cerebral FDG PET can provide new insights into mechanisms of
 perinatal hypoxic–ischaemic injury where early detection plays an important role in instituting therapy.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00259-011-2055-yAuthors
		Charlotte de Lange, Department of Paediatric Research, Oslo University Hospital, Rikshospitalet, P.O. Box 4950, Nydalen, 0424 Oslo, NorwayEirik Malinen, Department of Medical Physi...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661515</comments>
            <pubDate>Thu, 02 Feb 2012 06:55:54 +0100</pubDate>
            <guid isPermaLink="false">5661515</guid>        </item>
        <item>
            <title>PET/MRI in infectious and inflammatory diseases: will it be a useful improvement?</title>
            <link>http://www.medworm.com/index.php?rid=5661516&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2l7876v83t53m88k%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-5DOI 10.1007/s00259-012-2060-9Authors
		Andor W. J. M. Glaudemans, Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsAna Maria Quintero, Department of Radiology, Clinica Colsanitas S.A., Bogotà, ColombiaAlberto Signore, Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661516</comments>
            <pubDate>Wed, 01 Feb 2012 17:14:16 +0100</pubDate>
            <guid isPermaLink="false">5661516</guid>        </item>
        <item>
            <title>Myocardial perfusion imaging: a plus for coronary risk classification in diabetics</title>
            <link>http://www.medworm.com/index.php?rid=5661518&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdrg7184761k65p16%2F</link>
            <description>Content Type Journal ArticleCategory Editorial CommentaryPages 1-4DOI 10.1007/s00259-012-2067-2Authors
		Albert Flotats, Nuclear Medicine Department, Universitat Autònoma de Barcelona, Barcelona, Spain
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661518</comments>
            <pubDate>Tue, 31 Jan 2012 07:10:54 +0100</pubDate>
            <guid isPermaLink="false">5661518</guid>        </item>
        <item>
            <title>Comparative methods for PET image segmentation in pharyngolaryngeal squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5661517&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw012m557621l3376%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The BTVs delineated using the FCM-SW segmentation technique were seemingly the most accurate and approximated closely the
 3-D BTVs defined using the surgical specimens. Adaptive thresholding techniques need to be calibrated for each PET scanner
 and acquisition/processing protocol, and should not be used without optimization.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-2053-0Authors
		Habib Zaidi, Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211 Geneva, SwitzerlandMehrsima Abdoli, Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The NetherlandsCarolina Llina Fuentes, Division of Nuclear Medicin...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661517</comments>
            <pubDate>Tue, 31 Jan 2012 07:10:54 +0100</pubDate>
            <guid isPermaLink="false">5661517</guid>        </item>
        <item>
            <title>PET/CT imaging of 90Y radiation synovectomy</title>
            <link>http://www.medworm.com/index.php?rid=5661520&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc35367j616404683%2F</link>
            <description>Content Type Journal ArticleCategory Image of the MonthPages 1-2DOI 10.1007/s00259-011-2058-8Authors
		Thomas W. Barber, Department of Nuclear Medicine &amp; PET Centre, The Alfred Hospital, Melbourne, Australia 3004Kenneth S. K. Yap, Department of Nuclear Medicine &amp; PET Centre, The Alfred Hospital, Melbourne, Australia 3004Victor Kalff, Department of Nuclear Medicine &amp; PET Centre, The Alfred Hospital, Melbourne, Australia 3004
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661520</comments>
            <pubDate>Tue, 31 Jan 2012 07:10:53 +0100</pubDate>
            <guid isPermaLink="false">5661520</guid>        </item>
        <item>
            <title>Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy</title>
            <link>http://www.medworm.com/index.php?rid=5661519&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv327r5713l210488%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Dedicated breast imaging radiologists, newly trained to interpret MBI with the proposed lexicon, achieved high agreement and
 diagnostic accuracy.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-12DOI 10.1007/s00259-011-2054-zAuthors
		Amy Lynn Conners, Department of Radiology, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USACarrie B. Hruska, Department of Radiology, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USACindy L. Tortorelli, Department of Radiology, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USARobert W. Maxwell, Department of Radiology, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USADeborah J. Rhodes, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USAJudy C. Boughey, Department of General Surg...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661519</comments>
            <pubDate>Tue, 31 Jan 2012 07:10:53 +0100</pubDate>
            <guid isPermaLink="false">5661519</guid>        </item>
        <item>
            <title>Fluorodeoxyglucose PET/CT in subcutaneous sarcoidosis mimicking cutaneous lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=5651959&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn6468u7j354t6273%2F</link>
            <description>Content Type Journal ArticleCategory Image of the MonthPages 1-2DOI 10.1007/s00259-012-2068-1Authors
		Marcel P.M. Stokkel, Department of Nuclear Medicine, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The NetherlandsBernies van der Hiel, Department of Nuclear Medicine, Leiden University Medical Center, Leiden, The NetherlandsRenato Valdés Olmos, Department of Nuclear Medicine, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The NetherlandsKees Hoefnagel, Department of Nuclear Medicine, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingO...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651959</comments>
            <pubDate>Fri, 27 Jan 2012 17:56:38 +0100</pubDate>
            <guid isPermaLink="false">5651959</guid>        </item>
        <item>
            <title>Oliver Lindner: Myocardial Perfusion SPECT Imaging — a Practical Guide</title>
            <link>http://www.medworm.com/index.php?rid=5651960&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe40j62722p805125%2F</link>
            <description>Content Type Journal ArticleCategory Book ReviewPages 1-1DOI 10.1007/s00259-012-2063-6Authors
		Claudio Marcassa, Cardiology Department, S. Maugeri Fnd, IRCCS, Scientific Institute of Veruno, Veruno, NO, Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651960</comments>
            <pubDate>Fri, 27 Jan 2012 17:56:37 +0100</pubDate>
            <guid isPermaLink="false">5651960</guid>        </item>
        <item>
            <title>Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours</title>
            <link>http://www.medworm.com/index.php?rid=5651961&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq78r7kh47300n246%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;For differentiation of pancreatic tumours, FDG PET and FDG PET/CT showed a higher sensitivity but lower specificity than FLT
 PET. Interestingly, visual analysis of FLT PET led to two false-positive findings by misinterpreting physiological bowel uptake
 as pathological FLT uptake in the pancreas. Due to the limited number of patients, the clinical value of adding FLT PET to
 the diagnostic workup of pancreatic tumours remains to be determined.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-6DOI 10.1007/s00259-012-2061-8Authors
		K. Herrmann, Department of Nuclear Medicine, Technische Universität München, Ismaningerstr. 22, 81675 Munich, GermanyM. Erkan, Department of General Surgery, Technische Universität München, Munich, GermanyM. Dobritz...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651961</comments>
            <pubDate>Wed, 25 Jan 2012 18:07:45 +0100</pubDate>
            <guid isPermaLink="false">5651961</guid>        </item>
        <item>
            <title>PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2</title>
            <link>http://www.medworm.com/index.php?rid=5640099&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy9824q045865063n%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;PET imaging using one-step labeled 18F-AlF-NOTA-PRGD2 allows noninvasive visualization of ischemia/reperfusion-induced myocardial angiogenesis longitudinally.
 The favorable in vivo kinetics and easy production method of this integrin-targeted PET tracer facilitates its future clinical
 translation for lesion evaluation and therapy response monitoring in patients with occlusive cardiovascular diseases.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-10DOI 10.1007/s00259-011-2052-1Authors
		Haokao Gao, Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi’an, China 710032Lixin Lang, Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), Nation...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5640099</comments>
            <pubDate>Wed, 25 Jan 2012 06:53:51 +0100</pubDate>
            <guid isPermaLink="false">5640099</guid>        </item>
        <item>
            <title>Assessing global cardiovascular molecular calcification with 18F-fluoride PET/CT: will this become a clinical reality and a challenge to CT calcification scoring?</title>
            <link>http://www.medworm.com/index.php?rid=5640100&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk0h11624g0124424%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-5DOI 10.1007/s00259-011-2048-xAuthors
		Sandip Basu, Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Jerbai Wadia Road, Parel, Mumbai, 400012 IndiaPoul F. Høilund-Carlsen, Department of Nuclear Medicine, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, DenmarkAbass Alavi, Division of Nuclear Medicine, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5640100</comments>
            <pubDate>Tue, 24 Jan 2012 18:09:41 +0100</pubDate>
            <guid isPermaLink="false">5640100</guid>        </item>
        <item>
            <title>Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer</title>
            <link>http://www.medworm.com/index.php?rid=5640101&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F91v7608r20g57543%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;WBMTV is an independent predictor for progression and death in patients with SCLC. Incorporation of WBMTV with TNM staging
 can provide a more detailed prediction of prognosis than WBMTV with conventional staging as well as tumour staging alone.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-2059-7Authors
		Jong-Ryool Oh, Department of Nuclear Medicine, Chonnam National University Medical School and Hospital, 42, Jebong-no, Donggu, Gwangju, 501-757 Republic of KoreaJi-Hyoung Seo, Department of Nuclear Medicine, Daegu Fatima Hospital, Daegu, Republic of KoreaAri Chong, Department of Nuclear Medicine, Chonnam National University Medical School and Hospital, 42, Jebong-no, Donggu, Gwangju, 501-757 Republic of KoreaJung-Joon...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5640101</comments>
            <pubDate>Tue, 24 Jan 2012 07:19:33 +0100</pubDate>
            <guid isPermaLink="false">5640101</guid>        </item>
        <item>
            <title>The translocator protein ligand [18F]DPA-714 images glioma and activated microglia in vivo</title>
            <link>http://www.medworm.com/index.php?rid=5640102&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1u7514551665533k%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The TSPO radioligand [18F]DPA-714 can be used for PET imaging of intracranial 9L glioma in different rat strains. This preclinical study demonstrates
 the feasibility of employing [18F]DPA-714 as an alternative radiotracer to image human glioma.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-13DOI 10.1007/s00259-011-2041-4Authors
		Alexandra Winkeler, Inserm, U1023, Laboratoire d’Imagerie Moléculaire Expérimentale, Université Paris Sud, Orsay, FranceRaphael Boisgard, Inserm, U1023, Laboratoire d’Imagerie Moléculaire Expérimentale, Université Paris Sud, Orsay, FranceAli R. Awde, Inserm, U1023, Laboratoire d’Imagerie Moléculaire Expérimentale, Université Paris Sud, Orsay, FranceAlbertine Dubois, Inserm, U1023, Laboratoire d’Imager...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5640102</comments>
            <pubDate>Tue, 24 Jan 2012 07:19:32 +0100</pubDate>
            <guid isPermaLink="false">5640102</guid>        </item>
        <item>
            <title>Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies</title>
            <link>http://www.medworm.com/index.php?rid=5640103&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F873lq538752v8406%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Preliminary results showed that the distribution patterns of R1 and pAV-45 images are highly correlated with normalized FDG images, and the initial 5-min early time frame of 1–6&amp;nbsp;min is
 potentially useful in providing complementary FDG-like information to the amyloid plaque density by late-phase AV-45 images.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00259-011-2051-2Authors
		Ing-Tsung Hsiao, Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital, Taipei, TaiwanChin-Chang Huang, Department of Neurology, Chang Gung Memorial Hospital, Taipei, TaiwanChia-Ju Hsieh, Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital, Taipei, TaiwanWen-Chun Hsu, Departm...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5640103</comments>
            <pubDate>Tue, 24 Jan 2012 07:19:31 +0100</pubDate>
            <guid isPermaLink="false">5640103</guid>        </item>
        <item>
            <title>Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=5621915&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F465655n685j21314%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s00259-011-2046-zAuthors
		Mohsen Beheshti, Department of Nuclear Medicine &amp; Endocrinology, PET-CT Center Linz, St Vincent’s Hospital, Seilerstaette 4, 4020 Linz, AustriaWerner Langsteger, Department of Nuclear Medicine &amp; Endocrinology, PET-CT Center Linz, St Vincent’s Hospital, Seilerstaette 4, 4020 Linz, Austria
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621915</comments>
            <pubDate>Thu, 19 Jan 2012 06:51:13 +0100</pubDate>
            <guid isPermaLink="false">5621915</guid>        </item>
        <item>
            <title>Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: patterns of integration in therapy planning</title>
            <link>http://www.medworm.com/index.php?rid=5621914&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl21q38430027818t%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The metabolically active tumour volume observed in 11C-methionine PET differs from the volume of MRI by showing areas of infiltrative tumour and distinguishing from non-tumour
 lesions. Differences in 11C-methionine PET/MRI integration patterns can be assigned to tumour grades according to the WHO classification. This finding
 may improve tumour delineation and therapy planning for gliomas.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-2049-9Authors
		Javier Arbizu, Department of Nuclear Medicine, Clinica Universidad de Navarra, Avenida Pio XII, 36, 31008 Pamplona, SpainS. Tejada, Department of Neurosurgery, Clinica Universidad de Navarra, Avenida Pio XII, 36, 31008 Pamplona, SpainJ. M. Marti-Climent, Department of Nucl...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621914</comments>
            <pubDate>Thu, 19 Jan 2012 06:51:13 +0100</pubDate>
            <guid isPermaLink="false">5621914</guid>        </item>
        <item>
            <title>Reply to the letter “Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients”</title>
            <link>http://www.medworm.com/index.php?rid=5621916&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3277025178484035%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s00259-011-2047-yAuthors
		M. Picchio, Nuclear Medicine Department, Scientific Institute San Raffaele, Milan, ItalyP. Mapelli, Nuclear Medicine Department, University of Milano-Bicocca, Milan, ItalyF. Fallanca, Nuclear Medicine Department, Scientific Institute San Raffaele, Milan, ItalyC. Messa, Institute for Bioimaging and Molecular Physiology (IBFM), National Research Council, Milan, Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621916</comments>
            <pubDate>Thu, 19 Jan 2012 06:51:12 +0100</pubDate>
            <guid isPermaLink="false">5621916</guid>        </item>
        <item>
            <title>Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment</title>
            <link>http://www.medworm.com/index.php?rid=5612540&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F411644jm361626mt%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;These preliminary results suggest that PET with florbetapir is a safe and suitable biomarker for AD that can be used routinely
 in a clinical environment. However, the low specificity of the visual PET scan assessment could be improved by the use of
 specific training and automatic or semiautomatic quantification tools.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-2021-8Authors
		V. Camus, UMR INSERM U930-CNRS ERL 3106, Tours, FranceP. Payoux, INSERM U825, Toulouse, FranceL. Barré, Groupe de Développements Méthodologiques en Tomographie par Émission de Positons, CEA/DSV/I2BM/CI-NAPS UMR6232, Caen, FranceB. Desgranges, INSERM U1077, Caen, FranceT. Voisin, Université Paul Sabatier de Toulouse, Toulouse, FranceC. Tau...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612540</comments>
            <pubDate>Wed, 18 Jan 2012 06:59:36 +0100</pubDate>
            <guid isPermaLink="false">5612540</guid>        </item>
        <item>
            <title>Reply: Diagnosis of neuroendocrine tumours and the costs for different tracers – the real problem behind the scenes!</title>
            <link>http://www.medworm.com/index.php?rid=5612539&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc843188408v34932%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s00259-011-2011-xAuthors
		Nils F. Schreiter, Department of Nuclear Medicine, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyVikas Prasad, Department of Nuclear Medicine, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyMartin H. Maurer, Department of Nuclear Medicine, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyWinfried Brenner, Department of Nuclear Medicine, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuc...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612539</comments>
            <pubDate>Wed, 18 Jan 2012 06:59:36 +0100</pubDate>
            <guid isPermaLink="false">5612539</guid>        </item>
        <item>
            <title>Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail</title>
            <link>http://www.medworm.com/index.php?rid=5600449&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl3700585lq675410%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s00259-011-2036-1Authors
		Sauli Savolainen, University of Helsinki &amp; Helsinki University Central Hospital, POB 340, FI-00029 HUS Helsinki, FinlandMark Konijnenberg, Department of Nuclear Medicine, Erasmus MC, Rotterdam, The NetherlandsManuel Bardiès, INSERM, UMR892 – Centre de Recherche en Cancérologie, Nantes, FranceMichael Lassmann, Department of Nuclear Medicine, University of Würzburg, Oberdürrbacher Str. 6, 97080 Würzburg, GermanyLidia Strigari, Laboratory of Medical Physics and Expert System, Regina Elena Cancer Institute, IFO, Rome, ItalyCarlo Chiesa, Nuclear Medicine Unit, Foundation IRCCS, Istituto Nazionale Tumori, Milan, ItalyArturo Chiti, Nuclear Medicine IRCCS Humanitas, Via Manzoni 56, 200...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600449</comments>
            <pubDate>Thu, 12 Jan 2012 16:49:07 +0100</pubDate>
            <guid isPermaLink="false">5600449</guid>        </item>
        <item>
            <title>Feasibility of bremsstrahlung dosimetry for direct dose estimation in patients undergoing treatment with 90Y-ibritumomab tiuxetan</title>
            <link>http://www.medworm.com/index.php?rid=5600450&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb41573lr07015271%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Based on patient-specific dosimetry, the administered activity may be increased by an average factor of 2.4, indicating that
 most patients could be undertreated. The relative dosimetry approach based on planar imaging largely underestimates doses
 relative to reference values. Dosimetry based on planar bremsstrahlung imaging is not a dependable alternative to 111In dosimetry.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-2040-5Authors
		C. Arrichiello, Nuclear Medicine Department, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione “G. Pascale”, Napoli, ItalyL. Aloj, Nuclear Medicine Department, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione “G. Pascale”, Napoli, ItalyM. Mormile...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600450</comments>
            <pubDate>Thu, 12 Jan 2012 06:42:36 +0100</pubDate>
            <guid isPermaLink="false">5600450</guid>        </item>
        <item>
            <title>Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis</title>
            <link>http://www.medworm.com/index.php?rid=5600451&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F321l261540033028%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Therapy with both 225Ac-DOTA-F3 and 213Bi-DTPA-F3 increased survival of mice with peritoneal carcinomatosis. Mild renal toxicity of both constructs favours future
 therapeutic application.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-2023-6Authors
		Markus Essler, Department of Nuclear Medicine, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, GermanyFlorian C. Gärtner, Department of Nuclear Medicine, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, GermanyFrauke Neff, Institute of Pathology, Helmholtz Zentrum München, Neuherberg, GermanyBirgit Blechert, Department of Nuclear Medicine, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, GermanyReingard Se...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600451</comments>
            <pubDate>Thu, 12 Jan 2012 06:42:35 +0100</pubDate>
            <guid isPermaLink="false">5600451</guid>        </item>
        <item>
            <title>Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization</title>
            <link>http://www.medworm.com/index.php?rid=5600452&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj23mh27206774553%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;SPECT/CT is more efficacious than planar imaging in identifying digestive extrahepatic uptake sites, with extrahepatic uptake
 observed in one third of scans using the former procedure. However, more than half of the uptake sites in our study were vascular
 in nature, without therapeutic implications. The risk of coregistration errors must also be kept in mind.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-2033-4Authors
		Laurence Lenoir, Department of Nuclear Medicine, Comprehensive Cancer Institute Eugène Marquis, CS 44229, 35042 Rennes, FranceJulien Edeline, University of Rennes 1, 35043 Rennes, FranceYann Rolland, Department of Medical Imaging, Comprehensive Cancer Institute Eugène Marquis, CS 44229, 35042 Rennes, ...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600452</comments>
            <pubDate>Thu, 12 Jan 2012 06:42:34 +0100</pubDate>
            <guid isPermaLink="false">5600452</guid>        </item>
        <item>
            <title>Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients</title>
            <link>http://www.medworm.com/index.php?rid=5600453&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg7866v6163042xxk%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Scintigraphy with the use of 99mTc-HYNIC-IL-2 can be a tool for inflamed atherosclerotic (vulnerable) plaque visualization within CCA in ESRD patients. Quantitative
 results of carotid artery scintigraphy with 99mTc-HYNIC-IL-2 correlate with serum concentration of selected cardiovascular risk markers.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-10DOI 10.1007/s00259-011-2026-3Authors
		Marta Opalinska, Nuclear Medicine Unit, Department of Endocrinology, Jagiellonian University Medical School, ul. Kopernika 17, 31-501 Cracow, PolandTomasz Stompor, Department of Nephrology, Hypertensiology and Internal Medicine, Faculty of Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, PolandDorota Pach, Nuclear Medicine Unit, Department of Endoc...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600453</comments>
            <pubDate>Thu, 12 Jan 2012 06:42:32 +0100</pubDate>
            <guid isPermaLink="false">5600453</guid>        </item>
        <item>
            <title>Highlights of the EANM Congress 2011: Birmingham, UK</title>
            <link>http://www.medworm.com/index.php?rid=5586640&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm110hjv448855l7j%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The EANM Congress 2011 took place in Birmingham between the 15th and 19th October 2011 under the presidency of Professor Werner
 Langsteger. The attendance was reassuringly high, in line with other EANM congresses, despite the current ‘Eurozone Crisis’.
 Participants from 87 countries came along, met old friends and made new ones. They were presented with a massive programme
 of 1,480 abstracts, symposia, and CME, scientific, plenary and featured sessions. The industry made a substantial contribution
 to the success of the congress with 109 hardware, software and radiopharmaceutical companies demonstrating the latest technology
 and innovations in the field. A feature in this year’s congress was the emphasis on the role of the young generation. The
 highlight lect...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586640</comments>
            <pubDate>Wed, 11 Jan 2012 17:55:46 +0100</pubDate>
            <guid isPermaLink="false">5586640</guid>        </item>
        <item>
            <title>SPECT/CT versus MRI in patients with nonspecific pain of the hand and wrist – a pilot study</title>
            <link>http://www.medworm.com/index.php?rid=5586639&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6670q3p26505m117%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In this initial comparison, SPECT/CT showed higher specificity than MRI in the evaluation of causative pathologies in patients
 with nonspecific wrist pain. However, MRI was more sensitive. Thus, SPECT/CT was shown to be a useful problem-solving tool
 in the diagnostic work-up of these patients.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-10DOI 10.1007/s00259-011-2034-3Authors
		Martin W. Huellner, Department of Radiology and Nuclear Medicine, Lucerne Cantonal Hospital, CH-6004 Lucerne, SwitzerlandAlexander Bürkert, Department of Radiology and Nuclear Medicine, Lucerne Cantonal Hospital, CH-6004 Lucerne, SwitzerlandFlorian S. Schleich, Department of Radiology and Nuclear Medicine, Lucerne Cantonal Hospital, CH-6004 Lucerne, SwitzerlandMaja S...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586639</comments>
            <pubDate>Wed, 11 Jan 2012 17:55:46 +0100</pubDate>
            <guid isPermaLink="false">5586639</guid>        </item>
        <item>
            <title>Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification</title>
            <link>http://www.medworm.com/index.php?rid=5586638&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw51n671v33tp3773%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-1DOI 10.1007/s00259-011-1962-2Authors
		Alexander Kroiss, Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, AustriaDaniel Putzer, Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, AustriaChristian Uprimny, Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, AustriaClemens Decristoforo, Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, AustriaMichael Gabriel, Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, AustriaWolfram Santner, Department of Radiology, Innsbruck Medical University, Innsbruck, AustriaCh...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586638</comments>
            <pubDate>Wed, 11 Jan 2012 17:55:46 +0100</pubDate>
            <guid isPermaLink="false">5586638</guid>        </item>
        <item>
            <title>FP-CIT SPECT evaluation: time to go beyond visual assessment!</title>
            <link>http://www.medworm.com/index.php?rid=5586641&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl557400326811p73%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s00259-011-2042-3Authors
		A. Skanjeti, Nuclear Medicine Unit, San Luigi Hospital, University of Turin, Reg. Gonzole 10, 10043 Orbassano, ItalyT. Angusti, Nuclear Medicine Unit, San Luigi Hospital, University of Turin, Reg. Gonzole 10, 10043 Orbassano, ItalyM. Margheron, Nuclear Medicine Unit, San Luigi Hospital, University of Turin, Reg. Gonzole 10, 10043 Orbassano, ItalyM. Iudicello, Neurology 1, San Luigi Hospital, Orbassano, ItalyV. Podio, Nuclear Medicine Unit, San Luigi Hospital, University of Turin, Reg. Gonzole 10, 10043 Orbassano, Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Mol...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586641</comments>
            <pubDate>Wed, 11 Jan 2012 06:57:05 +0100</pubDate>
            <guid isPermaLink="false">5586641</guid>        </item>
        <item>
            <title>Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy</title>
            <link>http://www.medworm.com/index.php?rid=5586642&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn653126w72j0j30t%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Detection rate of 18F-choline imaging is closely related to PSA and PSA kinetics. In particular, 18F-choline PET/CT is recommended in patients with PSA &amp;gt;2&amp;nbsp;ng/ml, PSAdt ≤6&amp;nbsp;months and PSAve &amp;gt;2&amp;nbsp;ng/ml per year. CT is useful for
 detecting bone metastases that are not 18F-choline-avid. The use of intravenous contrast agent seems unnecessary.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00259-011-2030-7Authors
		Orazio Schillaci, Department of Biopathology and Diagnostic Imaging, Interventional, University “Tor Vergata”, Rome, ItalyFerdinando Calabria, Department of Nuclear Medicine and Molecular Imaging, IRCCS Neuromed, Pozzilli, ItalyMario Tavolozza, Department of Biopathology and Diagnostic Imaging, Interv...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586642</comments>
            <pubDate>Tue, 10 Jan 2012 06:48:21 +0100</pubDate>
            <guid isPermaLink="false">5586642</guid>        </item>
        <item>
            <title>Minimally invasive input function for 2-18F-fluoro-A-85380 brain PET studies</title>
            <link>http://www.medworm.com/index.php?rid=5586643&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp066m85116314m78%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;PBIF scaled with arterial samples accurately estimates Logan V
 T for 2-18F-fluoro-A-85380. Results obtained with PBIF were slightly better than those obtained with IDIF. Due to arteriovenous concentration
 differences, venous samples cannot be substituted for arterial samples.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-2004-9Authors
		Paolo Zanotti-Fregonara, Molecular Imaging Branch, National Institute of Mental Health, NIH, 10 Center Drive, MSC-1026, Bethesda, MD 20892-2035, USARenaud Maroy, CEA, DSV, I2BM, Service Hospitalier Frederic Joliot, Orsay, 91401 FranceMarie-Anne Peyronneau, CEA, DSV, I2BM, Service Hospitalier Frederic Joliot, Orsay, 91401 FranceRégine Trebossen, CEA, DSV, I2BM, Service Hospitalier Frede...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586643</comments>
            <pubDate>Mon, 09 Jan 2012 19:35:31 +0100</pubDate>
            <guid isPermaLink="false">5586643</guid>        </item>
        <item>
            <title>Novel electrophilic synthesis of 6-[18F]fluorodopamine and comprehensive biological evaluation</title>
            <link>http://www.medworm.com/index.php?rid=5586644&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx7772u326g242501%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;6-[18F]FDA was synthesised with good radiopharmaceutical quality and yields high enough for several human PET studies. The SA of
 6-[18F]FDA was improved by 50- to 500-fold compared to previous electrophilic methods. Uptake of 6-[18F]FDA was specific in various peripheral organs, indicating that 6-[18F]FDA PET can be used to investigate sympathoneural functions beyond cardiac studies when higher specific uptake is achieved.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-2032-5Authors
		Olli Eskola, Turku PET Centre, University of Turku, Radiopharmaceutical Chemistry Laboratory, Kiinamyllynkatu 4-8, 20520 Turku, FinlandTove J. Grönroos, Turku PET Centre, University of Turku, Medicity/PET Preclinical Imaging, Turku, Finla...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586644</comments>
            <pubDate>Mon, 09 Jan 2012 19:35:30 +0100</pubDate>
            <guid isPermaLink="false">5586644</guid>        </item>
        <item>
            <title>Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5573669&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm45526x8303525kg%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;
 18F-DOPA PET/CT seems to be the most useful imaging method for detecting recurrent MTC lesions in patients with elevated serum
 calcitonin levels, performing better than 18F-FDG and 68Ga-somatostatin analogue PET/CT. 18F-FDG may complement 18F-DOPA in patients with an aggressive tumour.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-12DOI 10.1007/s00259-011-2031-6Authors
		Giorgio Treglia, Institute of Nuclear Medicine, Policlinico A. Gemelli, Catholic University of the Sacred Heart, Largo Gemelli, 8, Rome, 00168 ItalyPaola Castaldi, Institute of Nuclear Medicine, Policlinico A. Gemelli, Catholic University of the Sacred Heart, Largo Gemelli, 8, Rome, 00168 ItalyMaria Felicia Villani, Institute of Nuclear Medicine, Policlinico A. Gemelli, Cath...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573669</comments>
            <pubDate>Fri, 06 Jan 2012 06:44:56 +0100</pubDate>
            <guid isPermaLink="false">5573669</guid>        </item>
        <item>
            <title>The reliability of glomerular filtration rate measured from plasma clearance: a multi-centre study of 1,878 healthy potential renal transplant donors</title>
            <link>http://www.medworm.com/index.php?rid=5573668&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw8616881663m0h52%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The CV of ECFV/BSA in normal subjects is a useful indicator of the technical robustness with which GFR is measured and, in
 this study, indicated a wide variation in departmental performance.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00259-011-2024-5Authors
		A. Michael Peters, Department of Nuclear Medicine, Royal Sussex County Hospital, Audrey Emerton Building, Eastern Road, Brighton, BN2 5BE UKBethany Howard, Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, UKMark D. J. Neilly, Department of Medical Physics, University Medical Unit, Glasgow Royal Infirmary, Glasgow, UKNagabhushan Seshadri, Department of Nuclear Medicine, Royal Liverpool University Hospital, Liverpool, UKRavin Sobnack, Department of Nucle...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573668</comments>
            <pubDate>Fri, 06 Jan 2012 06:44:56 +0100</pubDate>
            <guid isPermaLink="false">5573668</guid>        </item>
        <item>
            <title>Effect of stress testing on left ventricular mechanical synchrony by phase analysis of gated positron emission tomography in patients with normal myocardial perfusion</title>
            <link>http://www.medworm.com/index.php?rid=5573670&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr1709206n664567g%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;LV mechanical dyssynchrony indices by phase analysis are smaller when derived from peak stress versus rest gated PET imaging
 in patients with normal MPI, irrespective of the resting LVEF.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00259-011-2025-4Authors
		Wael AlJaroudi, Heart and Vascular Imaging Institutes, Cleveland Clinic, Cleveland, OH, USAM. Chadi Alraies, Heart and Vascular Imaging Institutes, Cleveland Clinic, Cleveland, OH, USAFrank DiFilippo, Heart and Vascular Imaging Institutes, Cleveland Clinic, Cleveland, OH, USARichard C. Brunken, Heart and Vascular Imaging Institutes, Cleveland Clinic, Cleveland, OH, USAManuel D. Cerqueira, Heart and Vascular Imaging Institutes, Cleveland Clinic, Cleveland, OH, USAWael A. Jabe...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573670</comments>
            <pubDate>Thu, 05 Jan 2012 06:52:13 +0100</pubDate>
            <guid isPermaLink="false">5573670</guid>        </item>
        <item>
            <title>Evolving paradigms for successful molecular imaging of medullary thyroid carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5573671&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F956p6h341q3055wr%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-6DOI 10.1007/s00259-011-2035-2Authors
		Domenico Rubello, Department of Nuclear Medicine, Medical Physics, Radiology, Santa Maria della Misericordia Hospital, Via Tre Martiri 140, 45100 Rovigo, ItalyKa Kit Wong, Department of Nuclear Medicine and Radiology, University of Michigan Hospital, Ann Arbor, MI, USAMaria Cristina Marzola, Department of Nuclear Medicine, Medical Physics, Radiology, Santa Maria della Misericordia Hospital, Via Tre Martiri 140, 45100 Rovigo, ItalyMohsen Beheshti, PET-CT Center Linz, Nuclear Medicine and Endocrinology, Sant Vincent’s Hospital, Linz, AustriaValentina Ambrosini, Department of Nuclear Medicine, Policlinico Sant’Orsola-Malpighi, Bologna University, Bologna, ItalySotirios Chondrogiannis, Departmen...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573671</comments>
            <pubDate>Thu, 05 Jan 2012 06:52:12 +0100</pubDate>
            <guid isPermaLink="false">5573671</guid>        </item>
        <item>
            <title>Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using 89Zr-ibritumomab tiuxetan and PET</title>
            <link>http://www.medworm.com/index.php?rid=5573673&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fxm462j02h3304510%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Biodistribution of 89Zr-ibritumomab tiuxetan is not influenced by simultaneous therapy with 90Y-ibritumomab tiuxetan, and 89Zr-ibritumomab tiuxetan scout scans can thus be used to predict biodistribution and dose-limiting organ during therapy. Absorbed
 doses to spleen were lower than those previously estimated using 111In-ibritumomab tiuxetan. The dose-limiting organ in patients undergoing stem cell transplantation is the liver.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-2008-5Authors
		Saiyada N. F. Rizvi, Department of Nuclear Medicine and PET Research, VU University Medical Center, PO Box 7057, De Boelelaan 1117, 1007 MB Amsterdam, The NetherlandsOtto J. Visser, Department of Haematology, VU University Medical Cen...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573673</comments>
            <pubDate>Wed, 04 Jan 2012 17:00:52 +0100</pubDate>
            <guid isPermaLink="false">5573673</guid>        </item>
        <item>
            <title>Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5573672&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff0582841327p7010%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-11DOI 10.1007/s00259-011-2045-0Authors
		Victor L. Villemagne, Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, VIC, AustraliaWilliam E. Klunk, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAChester A. Mathis, Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAChristopher C. Rowe, Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, VIC, AustraliaDavid J. Brooks, Department of Medicine, Imperial College London, London and GE Healthcare, Medical Diagnostics, Amersham, UKBradley T. Hyman, Department of Neurology, Harvard University, Boston, MA, USAMilos D. Ikonomovic, Department of Neurology, University ...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573672</comments>
            <pubDate>Wed, 04 Jan 2012 17:00:52 +0100</pubDate>
            <guid isPermaLink="false">5573672</guid>        </item>
        <item>
            <title>Hypertension complicating 131I-meta-iodobenzylguanidine therapy for neuroblastoma</title>
            <link>http://www.medworm.com/index.php?rid=5573674&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F17316n7413404106%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Clinically relevant hypertension following 131I-mIBG therapy affected less than 5% of administrations, but was more common in those patients with preexisting hypertension.
 As hypertensive episodes may occur many hours after treatment, close monitoring of BP needs to be continued for at least 48&amp;nbsp;h
 after administration of 131I-mIBG.
 
 
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-5DOI 10.1007/s00259-011-2022-7Authors
		Michael A. Kosmin, Department of Oncology, University College London Hospitals NHS Foundation Trust, First Floor Central, 250 Euston Road, London, NW1 2PG UKJamshed B. Bomanji, Department of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UKNicholas J. Cork, Department of Oncology, Univer...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573674</comments>
            <pubDate>Wed, 04 Jan 2012 07:00:44 +0100</pubDate>
            <guid isPermaLink="false">5573674</guid>        </item>
        <item>
            <title>Monitoring anti-inflammatory therapies in patients with atherosclerosis: FDG PET emerges as the method of choice</title>
            <link>http://www.medworm.com/index.php?rid=5539952&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5786536110r4574v%2F</link>
            <description>Content Type Journal ArticleCategory Editorial CommentaryPages 1-3DOI 10.1007/s00259-011-2027-2Authors
		M. Hacker, Department of Nuclear Medicine, University of Munich, Marchioninistr. 15, 81377 Munich, Germany
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539952</comments>
            <pubDate>Wed, 21 Dec 2011 20:07:34 +0100</pubDate>
            <guid isPermaLink="false">5539952</guid>        </item>
        <item>
            <title>Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy</title>
            <link>http://www.medworm.com/index.php?rid=5539954&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr720r60n06548704%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Although 177Lu-DOTA-TATE planar dosimetry scans exhibited a very good sensitivity for the detection of metastases, they failed to pick
 up 9% of lesions seen on the 68Ga-DOTA-TATE PET/CT. Three-dimensional dosimetry using single photon emission computed tomography/CT could be applied to investigate
 this issue further. Delayed (72&amp;nbsp;h) images are most suitable for drawing regions of interest for dosimetric calculations.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-2003-xAuthors
		Aurora Sainz-Esteban, Department of Nuclear Medicine, Hospital Universitario Marqués de Valdecilla, Santander, SpainVikas Prasad, Department of Nuclear Medicine and Centre for PET/CT, Zentralklinik Bad Berka, Robert Koch Allee-9, 99437 Bad...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539954</comments>
            <pubDate>Tue, 20 Dec 2011 06:48:56 +0100</pubDate>
            <guid isPermaLink="false">5539954</guid>        </item>
        <item>
            <title>Can FDG PET/CT monitor the response to hormonal therapy in breast cancer patients?</title>
            <link>http://www.medworm.com/index.php?rid=5539953&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa40700737w078555%2F</link>
            <description>Content Type Journal ArticleCategory Editorial CommentaryPages 1-4DOI 10.1007/s00259-011-2018-3Authors
		Laura Evangelista, Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto (IOV – IRCCS), Via Gattamelata, 64, 35128 Padova, ItalyDomenico Rubello, Department of Nuclear Medicine, Radiology, Medical Physics, ‘Santa Maria della Misericordia’ Hospital, Rovigo, ItalyGiorgio Saladini, Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto (IOV – IRCCS), Via Gattamelata, 64, 35128 Padova, Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539953</comments>
            <pubDate>Tue, 20 Dec 2011 06:48:56 +0100</pubDate>
            <guid isPermaLink="false">5539953</guid>        </item>
        <item>
            <title>Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study</title>
            <link>http://www.medworm.com/index.php?rid=5539955&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh62131w43677144u%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Metabolic response assessed by FDG PET/CT imaging in patients with metastatic breast cancer treated with endocrine therapy
 is predictive of the patients’ PFS.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-1981-zAuthors
		Nina Mortazavi-Jehanno, Service de Médecine nucléaire, Institut Curie, Hôpital René Huguenin, 35 rue Dailly, 92210 Saint-Cloud, FranceAnne-Laure Giraudet, Service de Médecine nucléaire, Institut Curie, Hôpital René Huguenin, 35 rue Dailly, 92210 Saint-Cloud, FranceLaurence Champion, Service de Médecine nucléaire, Institut Curie, Hôpital René Huguenin, 35 rue Dailly, 92210 Saint-Cloud, FranceFlorence Lerebours, Service d’oncologie médicale, Institut Curie, Hôpital René Huguenin, 92210...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539955</comments>
            <pubDate>Tue, 20 Dec 2011 06:48:55 +0100</pubDate>
            <guid isPermaLink="false">5539955</guid>        </item>
        <item>
            <title>Erratum to: Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset</title>
            <link>http://www.medworm.com/index.php?rid=5517074&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7521466504573314%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-1DOI 10.1007/s00259-011-2029-0Authors
		Angelina Cistaro, Positron Emission Tomography Center IRMET S.p.A, Turin, ItalyMaria Consuelo Valentini, Department of Neuroradiology, CTO Hospital, Turin, ItalyAdriano Chiò, Department of Neuroscience, ALS Center, University of Turin, Turin, ItalyFlavio Nobili, Department of Neurosciences, Clinical Neurophysiology Unit, Ophthalmology and Genetics, University of Genoa, Genoa, ItalyAndrea Calvo, Department of Neuroscience, ALS Center, University of Turin, Turin, ItalyCristina Moglia, Department of Neuroscience, ALS Center, University of Turin, Turin, ItalyAnna Montuschi, Department of Neuroscience, ALS Center, University of Turin, Turin, ItalySilvia Morbelli, Department of Internal Medicine, Nucle...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5517074</comments>
            <pubDate>Thu, 15 Dec 2011 16:49:07 +0100</pubDate>
            <guid isPermaLink="false">5517074</guid>        </item>
        <item>
            <title>18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma</title>
            <link>http://www.medworm.com/index.php?rid=5507897&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw176q53362u1029p%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;[18F]FBEM-[Cys40]-exendin-4 and [18F]FBEM-[Cys0]-exendin-4 have high affinity for GLP-1R and display similar in vitro cell internalization. The higher uptake into INS-1
 xenograft tumors exhibited by [18F]FBEM-[Cys40]-exendin-4 suggests that this compound would be the better tracer for imaging GLP-1R.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-1980-0Authors
		Dale O. Kiesewetter, Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), 31 Center Drive, Suite 1 C14, Bethesda, MD 20892, USAHaokao Gao, Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioenginee...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507897</comments>
            <pubDate>Wed, 14 Dec 2011 16:42:25 +0100</pubDate>
            <guid isPermaLink="false">5507897</guid>        </item>
        <item>
            <title>Direct comparison of 111In-labelled two-helix and three-helix Affibody molecules for in vivo molecular imaging</title>
            <link>http://www.medworm.com/index.php?rid=5507896&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F63pjn140q062108g%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;For tumours with high HER2 expression, two-helix HER2-targeting Affibody molecules can provide higher tumour-to-blood ratio
 at the cost of lower tumour uptake. In the case of low expression, both tumour uptake and tumour-to-organ ratios are appreciably
 higher for three-helix than for two-helix HER2-targeting Affibody molecules.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-10DOI 10.1007/s00259-011-2016-5Authors
		Daniel Rosik, Division of Molecular Biotechnology, School of Biotechnology, KTH Royal Institute of Technology, Stockholm, SwedenAnna Orlova, Preclinical PET Platform, Uppsala University, Uppsala, SwedenJennie Malmberg, Preclinical PET Platform, Uppsala University, Uppsala, SwedenMohamed Altai, Unit of Biomedical Radiation Sciences, R...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507896</comments>
            <pubDate>Wed, 14 Dec 2011 16:42:25 +0100</pubDate>
            <guid isPermaLink="false">5507896</guid>        </item>
        <item>
            <title>18F-Labelled exendin to image GLP-1 receptor-expressing tissues: from niche to blockbuster?</title>
            <link>http://www.medworm.com/index.php?rid=5507898&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F57g5740v02r27w84%2F</link>
            <description>Content Type Journal ArticleCategory Editorial CommentaryPages 1-2DOI 10.1007/s00259-011-2020-9Authors
		Otto C. Boerman, Department of Nuclear Medicine – 756, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The NetherlandsMartin Gotthardt, Department of Nuclear Medicine – 756, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507898</comments>
            <pubDate>Wed, 14 Dec 2011 16:42:24 +0100</pubDate>
            <guid isPermaLink="false">5507898</guid>        </item>
        <item>
            <title>Preclinical characterization of 18F-D-FPHCys, a new amino acid-based PET tracer</title>
            <link>http://www.medworm.com/index.php?rid=5507899&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F41812862441220p8%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The favourable properties of 18F-D-FPHCys make this tracer a promising imaging probe for detection of tumours as well as for the noninvasive evaluation and
 monitoring of tumour growth.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-10DOI 10.1007/s00259-011-2017-4Authors
		Delphine Denoyer, Molecular Imaging and Targeted Therapeutics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, AustraliaLaura Kirby, Molecular Imaging and Targeted Therapeutics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, AustraliaKelly Waldeck, Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaPeter Roselt, Molecular Imaging and Targeted Therapeutics Laboratory, Peter MacCallum...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507899</comments>
            <pubDate>Mon, 12 Dec 2011 17:06:23 +0100</pubDate>
            <guid isPermaLink="false">5507899</guid>        </item>
        <item>
            <title>Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT in Germany: two sides of two different coins</title>
            <link>http://www.medworm.com/index.php?rid=5497357&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F88346k84h2450647%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s00259-011-2010-yAuthors
		Juri Ruf, Klinik für Radiologie und Nuklearmedizin, Universitätsklinikum Magdeburg A.ö.R., Magdeburg, Germany
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5497357</comments>
            <pubDate>Fri, 09 Dec 2011 17:09:35 +0100</pubDate>
            <guid isPermaLink="false">5497357</guid>        </item>
        <item>
            <title>The dopaminergic system in patients with functional dyspepsia analysed by single photon emission computed tomography (SPECT) and an alpha-methyl-para-tyrosine (AMPT) challenge test</title>
            <link>http://www.medworm.com/index.php?rid=5497358&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq232167354330w31%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;These preliminary data suggest that chronic rather than acute alterations in the dopaminergic system may be involved in the
 pathogenesis of FD. Further studies are required to reproduce our novel findings and to evaluate to what extent the dopaminergic
 changes may be secondary to abnormalities in serotonergic pathways.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-2015-6Authors
		Breg Braak, Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The NetherlandsJan Booij, Department of Nuclear Medicine, Academic Medical Center, Amsterdam, The NetherlandsTamira K. Klooker, Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The NetherlandsRene M. J. van den Wijng...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5497358</comments>
            <pubDate>Thu, 08 Dec 2011 18:11:58 +0100</pubDate>
            <guid isPermaLink="false">5497358</guid>        </item>
        <item>
            <title>Suggested pathway to assess radiation safety of 11C-labeled PET tracers for first-in-human studies</title>
            <link>http://www.medworm.com/index.php?rid=5489421&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg7453435167821wr%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-4DOI 10.1007/s00259-011-2005-8Authors
		Paolo Zanotti-Fregonara, Molecular Imaging Branch, NIMH, NIH, 10 Center Drive, Bethesda, MD 20892-1026, USARobert B. Innis, Molecular Imaging Branch, NIMH, NIH, 10 Center Drive, Bethesda, MD 20892-1026, USA
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489421</comments>
            <pubDate>Wed, 07 Dec 2011 17:33:13 +0100</pubDate>
            <guid isPermaLink="false">5489421</guid>        </item>
        <item>
            <title>Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness</title>
            <link>http://www.medworm.com/index.php?rid=5489420&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F160t80q15qh5673l%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;A positive SLN in thin melanomas is uncommon with a prevalence of 4.1% in our study population. We could not identify reliable
 clinicopathological risk factors which could predict results of SLNB in thin melanomas. Based on our results, SLNB may be
 considered in patients with a melanoma of thickness in the range 0.90–0.99&amp;nbsp;mm, because all SLN-positive patients belonged
 to this subgroup.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00259-011-2009-4Authors
		Torsten Hinz, Department of Dermatology and Allergology, Center of Integrated Oncology (CIO) Cologne Bonn, University of Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, GermanyHojjat Ahmadzadehfar, Department of Nuclear Medicine, University of Bonn, Bonn, GermanyAnja Wierzbic...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489420</comments>
            <pubDate>Wed, 07 Dec 2011 17:33:13 +0100</pubDate>
            <guid isPermaLink="false">5489420</guid>        </item>
        <item>
            <title>ST-segment depression during vasodilator stress is of minor clinical importance in women with normal myocardial perfusion imaging and low or intermediate risk of coronary artery disease</title>
            <link>http://www.medworm.com/index.php?rid=5489422&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp116107048716260%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In patients with low-intermediate risk of CAD, “ischaemic” ECG changes during vasodilator stress combined with normal MPS
 are encountered mostly in women and are associated with a low prevalence of significant CAD and a low cardiac event rate.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-2007-6Authors
		Dimitris J. Apostolopoulos, Department of Nuclear Medicine, University of Patras Medical School, University Hospital of Patras, Rion, Patras, 26500 GreecePeriklis Davlouros, Department of Cardiology, University Hospital of Patras, University of Patras, Medical School, Patras, GreeceSotiria Alexiou, Department of Nuclear Medicine, University of Patras Medical School, University Hospital of Patras, Rion, Patras, 26500...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489422</comments>
            <pubDate>Wed, 07 Dec 2011 17:33:12 +0100</pubDate>
            <guid isPermaLink="false">5489422</guid>        </item>
        <item>
            <title>In memoriam: Jean-Luc Moretti</title>
            <link>http://www.medworm.com/index.php?rid=5489423&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff502026454332713%2F</link>
            <description>Content Type Journal ArticleCategory ObituaryPages 1-2DOI 10.1007/s00259-011-2006-7Authors
		Elif Hindié, Hôpital Saint-Louis, Paris, FranceDavid Groheux, Hôpital Saint-Louis, Paris, France
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489423</comments>
            <pubDate>Wed, 07 Dec 2011 16:44:22 +0100</pubDate>
            <guid isPermaLink="false">5489423</guid>        </item>
        <item>
            <title>Technical feasibility vs. clinical utility: a question of “can we?” vs. “should we?”</title>
            <link>http://www.medworm.com/index.php?rid=5489424&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx17405728237803t%2F</link>
            <description>Content Type Journal ArticleCategory Editorial CommentaryPages 1-2DOI 10.1007/s00259-011-2012-9Authors
		Ryan D. Niederkohr, Kaiser Permanente Medical Center, Santa Clara, CA, USA
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489424</comments>
            <pubDate>Wed, 07 Dec 2011 16:44:21 +0100</pubDate>
            <guid isPermaLink="false">5489424</guid>        </item>
        <item>
            <title>Downstream resource utilization following hybrid cardiac imaging with an integrated cadmium-zinc-telluride/64-slice CT device</title>
            <link>http://www.medworm.com/index.php?rid=5489425&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh621n72361x36u64%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Cardiac hybrid imaging in CAD evaluation has a profound impact on patient management and may contribute to optimal downstream
 resource utilization.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s00259-011-1999-2Authors
		Michael Fiechter, Department of Radiology, Cardiac Imaging, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, SwitzerlandJelena R. Ghadri, Department of Radiology, Cardiac Imaging, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, SwitzerlandMathias Wolfrum, Department of Radiology, Cardiac Imaging, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, SwitzerlandSilke M. Kuest, Department of Radiology, Cardiac Imaging, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, SwitzerlandAju P....</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489425</comments>
            <pubDate>Tue, 06 Dec 2011 06:59:07 +0100</pubDate>
            <guid isPermaLink="false">5489425</guid>        </item>
        <item>
            <title>18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials</title>
            <link>http://www.medworm.com/index.php?rid=5470836&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F72k114716400x201%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This study demonstrated that there is excellent short-term reproducibility in pulmonary 18F-FDG uptake in patients with IPF.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00259-011-1986-7Authors
		Thida Win, Respiratory Medicine, Lister Hospital, Stevenage, UKTryphon Lambrou, Institute of Nuclear Medicine, UCL/UCH, 235 Euston Road, London, NW1 2BU UKBrian F. Hutton, Institute of Nuclear Medicine, UCL/UCH, 235 Euston Road, London, NW1 2BU UKIrfan Kayani, Institute of Nuclear Medicine, UCL/UCH, 235 Euston Road, London, NW1 2BU UKNicholas J. Screaton, Radiology Department, Papworth Hospital, Cambridge, UKJoanna C. Porter, Centre for Respiratory Diseases, UCL/UCH, London, UKToby M. Maher, Interstitial Lung Disease Unit, Royal Brompton...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470836</comments>
            <pubDate>Wed, 30 Nov 2011 04:54:14 +0100</pubDate>
            <guid isPermaLink="false">5470836</guid>        </item>
        <item>
            <title>Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts</title>
            <link>http://www.medworm.com/index.php?rid=5470835&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F742053ln7740m760%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Since distant prostate cancer metastases are situated in bone or bone marrow, the higher tumour-to-bone ratio is the most
 important. This renders 111In-DOTA-ZHER2:S1 a preferable agent for imaging of HER2 expression in disseminated prostate cancer.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-12DOI 10.1007/s00259-011-1992-9Authors
		Jennie Malmberg, Preclinical PET Platform, Department of Medicinal Chemistry, Uppsala University, Uppsala, SwedenAnna Perols, Division of Molecular Biotechnology, School of Biotechnology, KTH Royal Institute of Technology, AlbaNova University Centre, 106 91 Stockholm, SwedenZohreh Varasteh, Preclinical PET Platform, Department of Medicinal Chemistry, Uppsala University, Uppsala, SwedenMohamed Altai, Unit of Biomed...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470835</comments>
            <pubDate>Wed, 30 Nov 2011 04:54:14 +0100</pubDate>
            <guid isPermaLink="false">5470835</guid>        </item>
        <item>
            <title>Demonstration of peripheral nerve root involvement by non-Hodgkin’s lymphoma on 18F-FDG PET/CT</title>
            <link>http://www.medworm.com/index.php?rid=5470838&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F075118vm7252mn58%2F</link>
            <description>Content Type Journal ArticleCategory Image of the MonthPages 1-2DOI 10.1007/s00259-011-2000-0Authors
		Henry Guo, Department of Radiology, Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Dr, H-2200, Stanford, CA 94305, USACamila Mosci, Department of Radiology, Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Dr, H-2200, Stanford, CA 94305, USAAndrei Iagaru, Department of Radiology, Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Dr, H-2200, Stanford, CA 94305, USA
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470838</comments>
            <pubDate>Tue, 29 Nov 2011 22:18:58 +0100</pubDate>
            <guid isPermaLink="false">5470838</guid>        </item>
        <item>
            <title>Multiphase contrast-enhanced CT with highly concentrated contrast agent can be used for PET attenuation correction in integrated PET/CT imaging</title>
            <link>http://www.medworm.com/index.php?rid=5470837&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg761310764v87040%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Multiphase CT data acquired with the use of highly concentrated CM can be used for qualitative assessment of liver lesions
 in torso FDG PET/CT. The influence on quantification of FDG uptake is small and negligible for most clinical applications.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-10DOI 10.1007/s00259-011-1919-5Authors
		Philip Aschoff, Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, GermanyChristian Plathow, Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, GermanyThomas Beyer, Imaging Science Institute, Tübingen, GermanyMatthias P. Lichy, Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Ge...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470837</comments>
            <pubDate>Tue, 29 Nov 2011 22:18:58 +0100</pubDate>
            <guid isPermaLink="false">5470837</guid>        </item>
        <item>
            <title>Ventricular dyssynchrony assessed by gated myocardial perfusion SPECT using a geometrical approach: a feasibility study</title>
            <link>http://www.medworm.com/index.php?rid=5451290&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5h46301hju02n531%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;It is feasible to quantify ventricular dyssynchrony in MPS using the geometrical approach as implemented by Corridor4DM.
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1991-xAuthors
		Berlinda J. van der Veen, Department of Nuclear Medicine, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The NetherlandsImad Al Younis, Department of Nuclear Medicine, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The NetherlandsNina Ajmone-Marsan, Department of Cardiology, Leiden University Medical Centre, Leiden, The NetherlandsJos J. M. Westenberg, Department of Radiology, Leiden University Medical Centre, Leiden, The NetherlandsJeroen J. Bax, Department of Cardiology, Leiden University Medical Centre, Leide...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5451290</comments>
            <pubDate>Thu, 24 Nov 2011 06:49:44 +0100</pubDate>
            <guid isPermaLink="false">5451290</guid>        </item>
        <item>
            <title>18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation</title>
            <link>http://www.medworm.com/index.php?rid=5451291&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl52277k8665j02p6%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In patients with MM in the post-transplant setting, 18F-FDG PET/CT may (1) contribute to the detection and localization of disease, (2) provide information about the extent of
 distinct myeloma manifestations and the total disease burden and (3) add information about the metabolic activity of disease,
 but (4) has substantially lower sensitivity for this purpose compared to the pretreatment setting.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00259-011-1993-8Authors
		Thorsten Derlin, Department of Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistraβe 52, 20246 Hamburg, GermanyChristoph Weber, Department of Diagnostic and Interventional Radiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germ...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5451291</comments>
            <pubDate>Thu, 24 Nov 2011 06:49:42 +0100</pubDate>
            <guid isPermaLink="false">5451291</guid>        </item>
        <item>
            <title>Imaging for metabotropic glutamate receptor subtype 1 in rat and monkey brains using PET with [18F]FITM</title>
            <link>http://www.medworm.com/index.php?rid=5451292&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F37113606r56k00rr%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;[18F]FITM has an excellent profile as a PET ligand for mGluR1 imaging. PET with [18F]FITM may prove useful for determining the regional distribution and density of mGluR1 and the mGluR1 occupancy of drugs
 in human brains.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-10DOI 10.1007/s00259-011-1995-6Authors
		Tomoteru Yamasaki, Molecular Imaging Centre, National Institute of Radiological Sciences, Chiba, JapanMasayuki Fujinaga, Molecular Imaging Centre, National Institute of Radiological Sciences, Chiba, JapanJun Maeda, Molecular Imaging Centre, National Institute of Radiological Sciences, Chiba, JapanKazunori Kawamura, Molecular Imaging Centre, National Institute of Radiological Sciences, Chiba, JapanJoji Yui, Molecular Imaging Centre, National...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5451292</comments>
            <pubDate>Thu, 24 Nov 2011 06:49:40 +0100</pubDate>
            <guid isPermaLink="false">5451292</guid>        </item>
        <item>
            <title>Microvascular dysfunction in nonfailing arrhythmogenic right ventricular cardiomyopathy</title>
            <link>http://www.medworm.com/index.php?rid=5451293&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft5r6n2775rq33163%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In this small well-characterized cohort of patients with nonfailing ARVC, we found a significantly reduced hyperaemic MBF
 and increased coronary vascular resistance. Further studies are necessary to corroborate this potential new functional aspect
 of the pathophysiological mechanisms underlying ARVC.
 
 
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-5DOI 10.1007/s00259-011-1985-8Authors
		Matthias Paul, Department of Cardiology and Angiology, University Hospital Münster, Albert-Schweitzer-Campus 1 – Gebäude A1, 48149 Münster, GermanyKambiz Rahbar, Department of Nuclear Medicine, University Hospital Münster, Münster, GermanyJoachim Gerss, Institute of Biostatistics and Clinical Research, University of Münster, Münster, GermanyPeter Kie...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5451293</comments>
            <pubDate>Thu, 24 Nov 2011 06:49:39 +0100</pubDate>
            <guid isPermaLink="false">5451293</guid>        </item>
        <item>
            <title>Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: a prospective, multicentre trial</title>
            <link>http://www.medworm.com/index.php?rid=5451294&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F47378065pr3l2285%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The addition of MPS imaging data to a prediction model based on traditional risk factors and ECG stress test data significantly
 improved CHD risk classification in patients with diabetes.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1983-xAuthors
		Wanda Acampa, Department of Biomorphological and Functional Sciences, University Federico II, Napoli, ItalyMario Petretta, Department of Clinical Medicine, Cardiovascular and Immunological Sciences, University Federico II, Napoli, ItalyLaura Evangelista, Department of Biomorphological and Functional Sciences, University Federico II, Napoli, ItalyStefania Daniele, SDN Foundation, Institute of Diagnostic and Nuclear Development, Napoli, ItalyEvgjeni Xhoxhi, Department of Biomo...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5451294</comments>
            <pubDate>Wed, 23 Nov 2011 16:32:39 +0100</pubDate>
            <guid isPermaLink="false">5451294</guid>        </item>
        <item>
            <title>PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model</title>
            <link>http://www.medworm.com/index.php?rid=5451296&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc8157212878175l4%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;With optimized liver blocking, [18F]FBEM-cEGF has the potential to be used in a noninvasive and quantitative manner for detection of malignant lesions and evaluation
 of EGFR activity.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1969-8Authors
		Weihua Li, Department of Medical Imaging and Nuclear Medicine, Fourth Affiliated Hospital, Harbin Medical University, 37 Yinhang Street, Nangang District, Harbin, 150001 ChinaGang Niu, Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), 31 Center Drive, Suite 1C14, Bethesda, MD 20892-2281, USALixin Lang, Laboratory of Molecular Imaging and Nanomedicine (LOMIN), Nationa...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5451296</comments>
            <pubDate>Tue, 22 Nov 2011 18:01:41 +0100</pubDate>
            <guid isPermaLink="false">5451296</guid>        </item>
        <item>
            <title>The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers</title>
            <link>http://www.medworm.com/index.php?rid=5451295&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flxu045t25200g707%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The medium dose of atorvastatin over a 12-week period resulted in a significant reduction of arterial inflammation as well
 as various circulating biomarkers.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1994-7Authors
		Yen-Wen Wu, Department of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanHsian-Li Kao, Department of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanChi-Lun Huang, Department of Internal Medicine, Tao-Yuan General Hospital, Tao-Yuan, TaiwanMing-Fong Chen, Department of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanLian-Yu Lin, Department of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanYi-Chih Wang, Department of...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5451295</comments>
            <pubDate>Tue, 22 Nov 2011 18:01:41 +0100</pubDate>
            <guid isPermaLink="false">5451295</guid>        </item>
        <item>
            <title>Prognostic significance of mediastinal 18F-FDG uptake in PET/CT in advanced ovarian cancer</title>
            <link>http://www.medworm.com/index.php?rid=5451297&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb02588h234g0411x%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Increased mediastinal 18F-FDG uptake was common in patients with advanced ovarian cancer. However, complete cytoreduction, which was significantly
 more frequent among patients without mediastinal 18F-FDG uptake, was the only factor independently associated with survival.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s00259-011-1984-9Authors
		Anne-Sophie Bats, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, FranceFlorent Hugonnet, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, FranceCyrille Huchon, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, FranceChérazade Bensaid, Assistance Publique-Hôpitaux de Paris, Service de Chirurgie G...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5451297</comments>
            <pubDate>Tue, 22 Nov 2011 18:01:40 +0100</pubDate>
            <guid isPermaLink="false">5451297</guid>        </item>
        <item>
            <title>Predictive value of dopamine transporter SPECT imaging with [123I]PE2I in patients with subtle parkinsonian symptoms</title>
            <link>http://www.medworm.com/index.php?rid=5433924&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw74n127208570650%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In drug-naive patients with subtle clinical parkinsonian motor symptoms, dopamine transporter scan using 123I-PE21 has a high sensitivity and specificity in distinguishing between patients with and without striatal neurodegeneration.
 The specificity is lower in patients who are also cognitively impaired. Calculation of the striatal APR can assist in differentiating
 between idiopathic Parkinson’s disease and atypical parkinsonian syndromes.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1976-9Authors
		Morten Ziebell, Neurobiology Research Unit &amp; Cimbi, Rigshospitalet and University of Copenhagen, N9201, 9 Blegdamsvej, Copenhagen, DK-2100 DenmarkBirgitte B. Andersen, Memory Disorders Research Group, Department of Neuro...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5433924</comments>
            <pubDate>Fri, 18 Nov 2011 06:58:41 +0100</pubDate>
            <guid isPermaLink="false">5433924</guid>        </item>
        <item>
            <title>Standardisation and harmonisation boost the credibility of nuclear medicine procedures</title>
            <link>http://www.medworm.com/index.php?rid=5424533&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv471706137471277%2F</link>
            <description>Content Type Journal ArticleCategory Editorial CommentaryPages 1-2DOI 10.1007/s00259-011-1996-5Authors
		Klaus Tatsch, Klinik für Nuklearmedizin, Städtisches Klinikum Karlsruhe, Moltkestr. 90, 76133 Karlsruhe, Germany
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424533</comments>
            <pubDate>Wed, 16 Nov 2011 16:45:56 +0100</pubDate>
            <guid isPermaLink="false">5424533</guid>        </item>
        <item>
            <title>Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123I-FP-CIT SPECT database</title>
            <link>http://www.medworm.com/index.php?rid=5424534&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl75p23t336x63351%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;A framework has been designed to produce high-quality data for multi-centre SPECT studies. This framework has been successfully
 applied to a pan-European initiative to acquire a healthy control dopamine transporter image database.
 
 
 
 
	Content Type Journal ArticleCategory GuidelinesPages 1-10DOI 10.1007/s00259-011-1884-zAuthors
		John Caddell Dickson, Institute of Nuclear Medicine, UCLH NHS Foundation Trust and University College London, London, UKLivia Tossici-Bolt, Department of Medical Physics and Bioengineering, Southampton University Hospitals NHS Trust, Southampton, UKTerez Sera, Department of Nuclear Medicine and Euromedic Szeged, University of Szeged, Szeged, HungaryRobin de Nijs, Neurobiology Research Unit, Rigshospitalet and University of Copenhagen, Co...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424534</comments>
            <pubDate>Wed, 16 Nov 2011 16:45:55 +0100</pubDate>
            <guid isPermaLink="false">5424534</guid>        </item>
        <item>
            <title>Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset</title>
            <link>http://www.medworm.com/index.php?rid=5424535&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4h1w877415574675%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This large FDG PET investigation provided unprecedented evidence of relatively increased metabolism in the amygdalae, midbrain
 and pons in ALS patients as compared with control subjects, possibly due to local activation of astrocytes and microglia.
 Highly significant relative decreases in metabolism were found in large frontal and parietal regions in the bulbar onset patients
 as compared with the spinal onset patients and the controls, suggesting a differential metabolic and neuropsychological state
 between the two conditions.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1979-6Authors
		Angelina Cistaro, Positron Emission Tomography Center IRMET S.p.A, Turin, ItalyMaria Consuelo Valentini, Department of Neuroradiolo...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424535</comments>
            <pubDate>Wed, 16 Nov 2011 16:45:54 +0100</pubDate>
            <guid isPermaLink="false">5424535</guid>        </item>
        <item>
            <title>Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy</title>
            <link>http://www.medworm.com/index.php?rid=5424536&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl036514nl6020124%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In a study cohort of patients with biochemical recurrence of prostate cancer after radical prostatectomy there emerged clear
 PSA thresholds for the presence of FC PET/CT-detectable lesions.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-12DOI 10.1007/s00259-011-1970-2Authors
		Vera Graute, Department of Nuclear Medicine, University of Munich, Marchioninistr. 15, 81377 Munich, GermanyNathalie Jansen, Department of Nuclear Medicine, University of Munich, Marchioninistr. 15, 81377 Munich, GermanyChristopher Übleis, Department of Nuclear Medicine, University of Munich, Marchioninistr. 15, 81377 Munich, GermanyMichael Seitz, Department of Urology, University of Munich, Munich, GermanyMarkus Hartenbach, Department of Nuclear Medicine, Bundeswehrkran...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424536</comments>
            <pubDate>Wed, 16 Nov 2011 06:48:09 +0100</pubDate>
            <guid isPermaLink="false">5424536</guid>        </item>
        <item>
            <title>Laparoscopic sentinel lymph node (SLN) versus extensive pelvic dissection for clinically localized prostate carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5424537&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3523634j3752885g%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Laparoscopy is suitable for broad identification of SLN metastasis, and targeted resection of these lymph nodes significantly
 limits the risk of extended surgical resection whilst maintaining the accuracy of the information.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1975-xAuthors
		Caroline Rousseau, Médecine Nucléaire, ICO René Gauducheau, Boulevard Monod, 44805 Saint Herblain Cedex, FranceThierry Rousseau, Clinique Urologique Nantes-Atlantis, Ave J. Cartier, 44800 Saint-Herblain, FranceBoumédiène Bridji, Médecine Nucléaire, ICO René Gauducheau, Boulevard Monod, 44805 Saint Herblain Cedex, FranceAmandine Pallardy, Médecine Nucléaire, ICO René Gauducheau, Boulevard Monod, 44805 Saint Herblain Cedex, Franc...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424537</comments>
            <pubDate>Tue, 15 Nov 2011 16:58:39 +0100</pubDate>
            <guid isPermaLink="false">5424537</guid>        </item>
        <item>
            <title>The effect of device-based cardiac contractility modulation therapy on myocardial efficiency and oxidative metabolism in patients with heart failure</title>
            <link>http://www.medworm.com/index.php?rid=5412608&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa534388812605910%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;These results indicate that CCM does not induce increased MVO2, even under stress conditions.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00259-011-1977-8Authors
		Georg Goliasch, Department of Cardiology, Vienna General Hospital/Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, AustriaAliasghar Khorsand, Department of Cardiology, Vienna General Hospital/Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, AustriaMatthias Schütz, Department of Nuclear Medicine, Vienna General Hospital/Medical University of Vienna, 1090 Vienna, AustriaGeorgios Karanikas, Department of Nuclear Medicine, Vienna General Hospital/Medical University of Vienna, 1090 Vienna, AustriaCesar Khazen, Department of Cardioth...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5412608</comments>
            <pubDate>Mon, 14 Nov 2011 16:51:59 +0100</pubDate>
            <guid isPermaLink="false">5412608</guid>        </item>
        <item>
            <title>Extremity doses of nuclear medicine personnel: a concern</title>
            <link>http://www.medworm.com/index.php?rid=5412609&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhhg67066k8793632%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-4DOI 10.1007/s00259-011-1973-zAuthors
		Gerrit J. Kemerink, Department of Nuclear Medicine, Maastricht University Medical Center, P. Debyelaan 25, 6229HX Maastricht, The NetherlandsFilip Vanhavere, Belgian Nuclear Research Centre SCK*CEN, Mol, BelgiumIlona Barth, Department of Radiation Protection and Health, Federal Office for Radiation Protection (BfS), Berlin, GermanyFelix M. Mottaghy, Department of Nuclear Medicine, Maastricht University Medical Center, P. Debyelaan 25, 6229HX Maastricht, The Netherlands
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5412609</comments>
            <pubDate>Mon, 14 Nov 2011 16:51:58 +0100</pubDate>
            <guid isPermaLink="false">5412609</guid>        </item>
        <item>
            <title>Measurement of SUVmax plus ADCmin of the primary tumour is a predictor of prognosis in patients with cervical cancer</title>
            <link>http://www.medworm.com/index.php?rid=5412611&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F42163pt145112701%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;High SUVmax together with low ADCmin of the primary tumour is an important predictive factor for identifying patients with
 cervical cancer who have a poor prognosis.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00259-011-1978-7Authors
		Keiichiro Nakamura, Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kika-ku, Okayama, 700-8558 JapanIkuo Joja, Department of Medical Radiotechnology, Okayama University Graduate School of Health Sciences, 2-5-1 Shikata-cho, Kika-ku, Okayama, 700-8558 JapanJunichi Kodama, Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5412611</comments>
            <pubDate>Wed, 09 Nov 2011 17:45:45 +0100</pubDate>
            <guid isPermaLink="false">5412611</guid>        </item>
        <item>
            <title>The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis</title>
            <link>http://www.medworm.com/index.php?rid=5412610&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc2x632v765gu175x%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;
 18F-FDG PET is a sensitive and specific imaging tool for large vessel vasculitis, especially when performed in patients not
 receiving immunosuppressive drugs. It increases the overall diagnostic accuracy and has an impact on the clinical management
 in a significant proportion of patients.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-10DOI 10.1007/s00259-011-1967-xAuthors
		Martin Fuchs, Institute of Nuclear Medicine, University Hospital, Petersgraben 4, 4031 Basel, SwitzerlandMatthias Briel, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, SwitzerlandThomas Daikeler, Department of Rheumatology, University Hospital Basel, Basel, SwitzerlandUlrich A. Walker, Department of Rheumatology of Basle Un...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5412610</comments>
            <pubDate>Wed, 09 Nov 2011 17:45:45 +0100</pubDate>
            <guid isPermaLink="false">5412610</guid>        </item>
        <item>
            <title>Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy</title>
            <link>http://www.medworm.com/index.php?rid=5412612&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F664197506755h367%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The current study demonstrated that 18F-FDG and 18F-NaF can be combined in a single PET/CT scan by administering the two radiopharmaceuticals simultaneously or in sequence
 on the same day. In addition to patient convenience and reduced radiation exposure from the CT component, the combined 18F-FDG/18F-NaF PET/CT scan appeared to increase the sensitivity for detection of osseous lesions compared to the 18F-FDG-only PET/CT scan in the studied population.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1971-1Authors
		Frank I. Lin, Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Dr, Room H-2230, Stanford, CA 94305, USAJyotsna E. Rao, Apollo Gleneagles PET-CT Centre, Hyderabad, IndiaErik S. Mittr...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5412612</comments>
            <pubDate>Tue, 08 Nov 2011 06:47:32 +0100</pubDate>
            <guid isPermaLink="false">5412612</guid>        </item>
        <item>
            <title>Estimation of regional bone metabolism from whole-body 18F-fluoride PET static images</title>
            <link>http://www.medworm.com/index.php?rid=5412613&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm051675639240015%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;
 18F-Fluoride bone plasma clearance can be estimated from a static scan and venous blood samples acquired 30–60&amp;nbsp;min after injection.
 The method enables K
 
 i
 to be estimated at multiple skeletal sites with a single injection of tracer.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s00259-011-1966-yAuthors
		Musib Siddique, King’s College London, Osteoporosis Screening &amp; Research Unit, Guy’s Hospital, 1st Floor, Tower Wing, London, SE1 9RT UKGlen M. Blake, King’s College London, Osteoporosis Screening &amp; Research Unit, Guy’s Hospital, 1st Floor, Tower Wing, London, SE1 9RT UKMichelle L. Frost, King’s College London, Osteoporosis Screening &amp; Research Unit, Guy’s Hospital, 1st Floor, Tower Wing, London, SE1 9RT U...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5412613</comments>
            <pubDate>Tue, 08 Nov 2011 06:47:31 +0100</pubDate>
            <guid isPermaLink="false">5412613</guid>        </item>
        <item>
            <title>Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis</title>
            <link>http://www.medworm.com/index.php?rid=5391869&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu648311316n22676%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The increased 99mTc-MDP skeletal uptake with teriparatide indicated increased bone formation which was supported by BTM increases. After 6&amp;nbsp;months
 off therapy, metabolic activity diminished towards baseline. The modulation of 99mTc-MDP skeletal uptake during treatment was the result of teriparatide’s metabolic activity. These findings may aid the radiological
 evaluation of similar teriparatide patients having radionuclide bone scans.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-1974-yAuthors
		Amelia E. B. Moore, Department of Nuclear Medicine, Borough Wing; Guy’s Hospital, King’s College London School of Medicine, St. Thomas Street, London, SE1 9RT UKGlen M. Blake, Department of Nuclear Medicine, Borough W...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391869</comments>
            <pubDate>Fri, 04 Nov 2011 16:51:00 +0100</pubDate>
            <guid isPermaLink="false">5391869</guid>        </item>
        <item>
            <title>Nuclear medicine, scientific publishing and the era of cost containment</title>
            <link>http://www.medworm.com/index.php?rid=5391870&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh29w051x16684364%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-3DOI 10.1007/s00259-011-1982-yAuthors
		Ignasi Carrió, Nuclear Medicine Department, Hospital Sant Pau, Barcelona, Spain
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391870</comments>
            <pubDate>Thu, 03 Nov 2011 16:56:01 +0100</pubDate>
            <guid isPermaLink="false">5391870</guid>        </item>
        <item>
            <title>Erratum to: Voriconazole-induced periostitis</title>
            <link>http://www.medworm.com/index.php?rid=5368320&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F61303j1g131708x4%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-1DOI 10.1007/s00259-011-1972-0Authors
		Christine Rossier, Department of Nuclear Medicine, CHUV and University of Lausanne, Lausanne, SwitzerlandVincent Dunet, Department of Nuclear Medicine, CHUV and University of Lausanne, Lausanne, SwitzerlandFrederic Tissot, Department of Medicine, Infectious Diseases Service, CHUV and University of Lausanne, Lausanne, SwitzerlandBerengère Aubry-Rozier, Center of Bones Diseases, CHUV and University of Lausanne, Lausanne, SwitzerlandOscar Marchetti, Department of Medicine, Infectious Diseases Service, CHUV and University of Lausanne, Lausanne, SwitzerlandAriane Boubaker, Department of Nuclear Medicine, CHUV and University of Lausanne, Lausanne, Switzerland
	

	
		Journal European Journal of Nuclear ...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5368320</comments>
            <pubDate>Fri, 28 Oct 2011 17:11:22 +0100</pubDate>
            <guid isPermaLink="false">5368320</guid>        </item>
        <item>
            <title>Direct relationship between cell density and FDG uptake in asymptomatic aortic aneurysm close to surgical threshold: an in vivo and in vitro study</title>
            <link>http://www.medworm.com/index.php?rid=5351043&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fxu06150m628p2842%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The loss of tissue structure and the marked decrease in cell density account for the low prevalence of positive findings at
 FDG PET imaging, at least in asymptomatic patients bearing AAAs whose diameter is close to surgical indication.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-1955-1Authors
		Cecilia Marini, CNR Institute of Bioimaging and Molecular Physiology, Milan, Genoa Section, Genoa, ItalySilvia Morbelli, Department Internal Medicine, Chair of Nuclear Medicine, University of Genoa, Genoa, ItalyRiccardo Armonino, Department Internal Medicine, Chair of Nuclear Medicine, University of Genoa, Genoa, ItalyGiovanni Spinella, Division of Vascular and Endovascular Surgery, San Martino University Hospital, University ...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5351043</comments>
            <pubDate>Thu, 20 Oct 2011 05:56:37 +0100</pubDate>
            <guid isPermaLink="false">5351043</guid>        </item>
        <item>
            <title>Reliability of striatal [11C]raclopride binding in smokers wearing transdermal nicotine patches</title>
            <link>http://www.medworm.com/index.php?rid=5339508&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4hhk33811j621753%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Baseline RAC binding is highly reproducible in smokers wearing nicotine patches. This suggests that TNP are an acceptable
 method for controlling cigarette craving during studies that utilize RAC to examine changes in dopamine.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-6DOI 10.1007/s00259-011-1965-zAuthors
		Karmen K. Yoder, Indiana University Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USADaniel S. Albrecht, Indiana University Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USADavid A. Kareken, Indiana University Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USALauren M. Federici, Indiana University Center for Neuroimaging, Indiana U...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5339508</comments>
            <pubDate>Wed, 19 Oct 2011 05:55:46 +0100</pubDate>
            <guid isPermaLink="false">5339508</guid>        </item>
        <item>
            <title>Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study</title>
            <link>http://www.medworm.com/index.php?rid=5339511&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj0016965m30307r6%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Standardization of H/M ratios by the heart-chest calibration phantom method is feasible among different collimator types.
 This method could be practically used for multicentre comparison of H/M ratios.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s00259-011-1963-1Authors
		Kenichi Nakajima, Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Kanazawa, 920-8641 JapanKoichi Okuda, Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Kanazawa, 920-8641 JapanShinro Matsuo, Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Kanazawa, 920-8641 JapanMitsuhiro Yoshita, Department of Neurology, Kanazawa University Hospital, Kanazawa, JapanJunichi Taki, Department of Nuclear Medicine, Kanazawa U...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5339511</comments>
            <pubDate>Wed, 19 Oct 2011 05:55:45 +0100</pubDate>
            <guid isPermaLink="false">5339511</guid>        </item>
        <item>
            <title>Nuclear medicine is to Fukushima as drug is to poison: El sueño de la razón produce monstruos</title>
            <link>http://www.medworm.com/index.php?rid=5339510&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft141q2p47w5h1302%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-4DOI 10.1007/s00259-011-1964-0Authors
		Luigi Mansi, Nuclear Medicine, Second University of Naples, Piazza Miraglia, Naples, 80138 Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5339510</comments>
            <pubDate>Wed, 19 Oct 2011 05:55:45 +0100</pubDate>
            <guid isPermaLink="false">5339510</guid>        </item>
        <item>
            <title>Amyloid-β imaging with PET in Alzheimer’s disease: is it feasible with current radiotracers and technologies?</title>
            <link>http://www.medworm.com/index.php?rid=5339509&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3m8667713037384u%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-7DOI 10.1007/s00259-011-1960-4Authors
		Mateen C. Moghbel, Department of Radiology, Hospital of University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USABabak Saboury, Department of Radiology, Hospital of University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USASandip Basu, Radiation Medicine Center (BARC), Tata Memorial Hospital, Mumbai, IndiaScott D. Metzler, Department of Radiology, Hospital of University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USADrew A. Torigian, Department of Radiology, Hospital of University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USABengt Långström, Department of Biochemistry and Organic Chemistry, Uppsala University, Uppsala, Swed...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5339509</comments>
            <pubDate>Wed, 19 Oct 2011 05:55:45 +0100</pubDate>
            <guid isPermaLink="false">5339509</guid>        </item>
        <item>
            <title>Coronary risk factors and myocardial blood flow in patients evaluated for coronary artery disease: a quantitative [15O]H2O PET/CT study</title>
            <link>http://www.medworm.com/index.php?rid=5339512&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F47657w7715x047nk%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Gender, age and body mass index substantially influence reference values and should be corrected for when interpreting hyperaemic
 MBF values.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-1956-0Authors
		Ibrahim Danad, Department of Cardiology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The NetherlandsPieter G. Raijmakers, Department of Nuclear Medicine &amp; PET Research, VU University Medical Center, Amsterdam, The NetherlandsYolande E. Appelman, Department of Cardiology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The NetherlandsHendrik J. Harms, Department of Nuclear Medicine &amp; PET Research, VU University Medical Center, Amsterdam, The NetherlandsStefan de Haan, Departme...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5339512</comments>
            <pubDate>Tue, 18 Oct 2011 05:59:42 +0100</pubDate>
            <guid isPermaLink="false">5339512</guid>        </item>
        <item>
            <title>Changing paradigms in radioguided surgery and intraoperative imaging: the GOSTT concept</title>
            <link>http://www.medworm.com/index.php?rid=5326524&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff3x244037q160g30%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-3DOI 10.1007/s00259-011-1951-5Authors
		John J. Zaknun, Section of Nuclear Medicine, Division of Human Health, International Atomic Energy Agency (IAEA), 5 Wagramerstrasse, PO Box 200, Room A-2278, 1400 Vienna, AustriaFrancesco Giammarile, Nuclear Medicine Service, Hospices Civils de Lyon and EA3738 Faculté de Médecine, Lyon, FranceRenato A. Valdés Olmos, Department of Nuclear Medicine, Division of Diagnostic Oncology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsSergi Vidal-Sicart, Department of Nuclear Medicine, Hospital Clinic, Barcelona, SpainGiuliano Mariani, Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa, Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular Imagi...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5326524</comments>
            <pubDate>Fri, 14 Oct 2011 05:50:28 +0100</pubDate>
            <guid isPermaLink="false">5326524</guid>        </item>
        <item>
            <title>Imaging of neuroinflammation</title>
            <link>http://www.medworm.com/index.php?rid=5326523&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fym2w86v070727j67%2F</link>
            <description>Content Type Journal ArticleCategory Editorial CommentaryPages 1-4DOI 10.1007/s00259-011-1959-xAuthors
		Andrea Ciarmiello, Nuclear Medicine, S. Andrea Hospital, Via V. Veneto 197, 19100 La Spezia, Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5326523</comments>
            <pubDate>Fri, 14 Oct 2011 05:50:28 +0100</pubDate>
            <guid isPermaLink="false">5326523</guid>        </item>
        <item>
            <title>Osteoblastic healing response: discordant PET/CT findings</title>
            <link>http://www.medworm.com/index.php?rid=5326526&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe2t358p660152314%2F</link>
            <description>Content Type Journal ArticleCategory Image of the MonthPages 1-2DOI 10.1007/s00259-011-1953-3Authors
		Filip Gemmel, Department of Nuclear Medicine, AZ Alma Sijsele, Campus Sijsele, Gentse Steenweg 132, 8340 Sijsele-Damme, BelgiumSilvia A. Eshuis, Department of Nuclear Medicine, Medical Center Leeuwarden, Leeuwarden, The NetherlandsFemke van Vollenhoven, Department of Pulmonary Medicine, The Tjongerschans, Heerenveen, The NetherlandsPaul Gemmel, The Faculty of Economics and Business Administration, Ghent University, Ghent, Belgium
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5326526</comments>
            <pubDate>Fri, 14 Oct 2011 05:50:27 +0100</pubDate>
            <guid isPermaLink="false">5326526</guid>        </item>
        <item>
            <title>18F-FDG PET to identify soft tissue disease in multiple myeloma</title>
            <link>http://www.medworm.com/index.php?rid=5326525&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F758vg1272576147t%2F</link>
            <description>Content Type Journal ArticleCategory Image of the MonthPages 1-2DOI 10.1007/s00259-011-1957-zAuthors
		Sharon F. Hain, Department Nuclear Medicine, Royal North Shore Hospital, St Leonards, 2065 NSW, AustraliaSobia Khan, Department Nuclear Medicine, Royal North Shore Hospital, St Leonards, 2065 NSW, AustraliaWilliam Stevenson, Department of Haematology, Royal North Shore Hospital, St Leonards, 2065 NSW, Australia
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5326525</comments>
            <pubDate>Fri, 14 Oct 2011 05:50:27 +0100</pubDate>
            <guid isPermaLink="false">5326525</guid>        </item>
        <item>
            <title>A pharmacokinetic PET study of NK1 receptor occupancy</title>
            <link>http://www.medworm.com/index.php?rid=5317875&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb2158770v877x01m%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;These results indicate that after chronic dosing, casopitant can achieve a degree of NK1 receptor occupancy higher than those that have previously been tested in studies of clinical depression.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-10DOI 10.1007/s00259-011-1954-2Authors
		Stefano Zamuner, GlaxoSmithKline, Clinical Pharmacology Modeling &amp; Simulation, Stockley Park, UKEugenii A. Rabiner, GlaxoSmithKline, Clinical Imaging Centre, Hammersmith Hospital, London, UKSofia A. Fernandes, GlaxoSmithKline, Neurosciences CEDD, Verona, ItalyMassimo Bani, GlaxoSmithKline, Neurosciences CEDD, Verona, ItalyRoger N. Gunn, GlaxoSmithKline, Clinical Imaging Centre, Hammersmith Hospital, London, UKRoberto Gomeni, GlaxoSmithKline, Pharmacometrics, Upper Meri...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317875</comments>
            <pubDate>Wed, 12 Oct 2011 16:33:27 +0100</pubDate>
            <guid isPermaLink="false">5317875</guid>        </item>
        <item>
            <title>Early evaluation of cerebral metabolic rate of glucose (CMRglu) with 18F-FDG PET/CT and clinical assessment in idiopathic normal pressure hydrocephalus (INPH) patients before and after ventricular shunt placement: preliminary experience</title>
            <link>http://www.medworm.com/index.php?rid=5317876&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjp983263288176m2%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our preliminary data show that changes in the CMRglu are promptly reversible after surgery and that there is a relationship
 between the early metabolic changes and clinical symptoms, independently from the simultaneous changes in the ventricular
 size. The remarkable and prompt improvement in the global CMRglu and in symptoms may also have important implications for
 the current concept of “neuronal plasticity” and for the cells’ reactivity in order to recover their metabolic function.
 
 
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-6DOI 10.1007/s00259-011-1950-6Authors
		Maria Lucia Calcagni, Institute of Nuclear Medicine, Università Cattolica del Sacro Cuore, Largo A. Gemelli, 8, 00168 Rome, ItalyMariadea Lavalle, Institute of Nuclea...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317876</comments>
            <pubDate>Wed, 12 Oct 2011 16:33:25 +0100</pubDate>
            <guid isPermaLink="false">5317876</guid>        </item>
        <item>
            <title>Erratum to: ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis</title>
            <link>http://www.medworm.com/index.php?rid=5307111&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp4331u16520052j2%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-1DOI 10.1007/s00259-011-1961-3Authors
		Maya Damianovich, NeuroSurvival Technologies (NST) Ltd., 5 Odem St., Kiryat Matalon, Petah Tikva, 49170 IsraelIlan Ziv, NeuroSurvival Technologies (NST) Ltd., 5 Odem St., Kiryat Matalon, Petah Tikva, 49170 IsraelSamuel N. Heyman, Department of Medicine, Hadassah Hospital, Mt. Scopus and the Hebrew University Medical School, Jerusalem, IsraelSeymour Rosen, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USAAhuva Shina, Department of Medicine, Hadassah Hospital, Mt. Scopus and the Hebrew University Medical School, Jerusalem, IsraelDvora Kidron, Department of Pathology, Meir Hospital, Kfar-Saba, IsraelTali Aloya, NeuroSurvival Technologies (NST) L...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307111</comments>
            <pubDate>Sat, 08 Oct 2011 05:50:21 +0100</pubDate>
            <guid isPermaLink="false">5307111</guid>        </item>
        <item>
            <title>A comparative small-animal PET evaluation of [11C]tariquidar, [11C]elacridar and (R)-[11C]verapamil for detection of P-glycoprotein-expressing murine breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=5307110&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy5r92p524382574u%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Among the tested radiotracers, [11C]tariquidar performed best in discriminating tumours expressing high and low levels of Pgp. Therefore [11C]tariquidar merits further investigation as a PET tracer to assess Pgp expression levels in solid tumours.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-1941-7Authors
		Thomas Wanek, Health &amp; Environment Department, Molecular Medicine, AIT Austrian Institute of Technology GmbH, 2444 Seibersdorf, AustriaClaudia Kuntner, Health &amp; Environment Department, Molecular Medicine, AIT Austrian Institute of Technology GmbH, 2444 Seibersdorf, AustriaJens P. Bankstahl, Department of Pharmacology, Toxicology &amp; Pharmacy, University of Veterinary Medicine Hannover, Hannover, GermanyMarion Bankstah...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307110</comments>
            <pubDate>Sat, 08 Oct 2011 05:50:21 +0100</pubDate>
            <guid isPermaLink="false">5307110</guid>        </item>
        <item>
            <title>Radioembolisation of hepatocellular carcinoma patients using 90Y-labelled microspheres: towards a diffusion of the technique?</title>
            <link>http://www.medworm.com/index.php?rid=5307112&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F73x2t1274w1nk385%2F</link>
            <description>Content Type Journal ArticleCategory Editorial CommentaryPages 1-3DOI 10.1007/s00259-011-1952-4Authors
		Etienne Garin, Department of Nuclear Medicine, Comprehensive Cancer Institute Eugène Marquis, CS 44229, 35042 Rennes, France
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307112</comments>
            <pubDate>Sat, 08 Oct 2011 05:50:20 +0100</pubDate>
            <guid isPermaLink="false">5307112</guid>        </item>
        <item>
            <title>The significance of bremsstrahlung SPECT/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects</title>
            <link>http://www.medworm.com/index.php?rid=5298856&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff151650473p37955%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Despite the low quality of BS images, BS SPECT/CT can be used as a reliable method to confirm the safe distribution of 90Y microspheres and in the prediction of GI side effects.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s00259-011-1940-8Authors
		Hojjat Ahmadzadehfar, Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, GermanyMarianne Muckle, Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, GermanyAmir Sabet, Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, GermanyKai Wilhelm, Department of Radiology, University Hospital Bonn, Bonn, GermanyChristiane Kuhl, Department of Radiology, University Hospital ...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5298856</comments>
            <pubDate>Thu, 06 Oct 2011 06:29:10 +0100</pubDate>
            <guid isPermaLink="false">5298856</guid>        </item>
        <item>
            <title>Razelle Kurzrock, Maurie Markman (eds): Targeted Cancer Therapy</title>
            <link>http://www.medworm.com/index.php?rid=5298857&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fllw4268j3664g6h1%2F</link>
            <description>Content Type Journal ArticleCategory Book ReviewPages 1-2DOI 10.1007/s00259-011-1948-0Authors
		Luigi Mansi, Nuclear Medicine, Second University of Naples, Naples, ItalyAndrea Vaccaro, Nuclear Medicine, Second University of Naples, Naples, Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5298857</comments>
            <pubDate>Wed, 05 Oct 2011 05:47:37 +0100</pubDate>
            <guid isPermaLink="false">5298857</guid>        </item>
        <item>
            <title>Douglas Van Nostrand, Leonard Wartofsky, Gary Bloom, Kanchan P. Kulkarni (eds): Thyroid Cancer: a Guide for Patients</title>
            <link>http://www.medworm.com/index.php?rid=5298860&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj84k5w13788g5l56%2F</link>
            <description>Content Type Journal ArticleCategory Book ReviewPages 1-2DOI 10.1007/s00259-011-1945-3Authors
		Luigi Mansi, Nuclear Medicine, Second University of Naples, Naples, ItalyCinzia Landolfi, Nuclear Medicine, Second University of Naples, Naples, Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5298860</comments>
            <pubDate>Wed, 05 Oct 2011 05:47:35 +0100</pubDate>
            <guid isPermaLink="false">5298860</guid>        </item>
        <item>
            <title>Kenneth A. Ellenbogen, Mark A. Wood (eds): Cardiac Pacing and ICDs (5th edition)</title>
            <link>http://www.medworm.com/index.php?rid=5298859&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3726448p7r53548m%2F</link>
            <description>Content Type Journal ArticleCategory Book ReviewPages 1-1DOI 10.1007/s00259-011-1946-2Authors
		Luigi Mansi, Nuclear Medicine, Second University of Naples, Naples, ItalyCarmela Nappi, Nuclear Medicine, Second University of Naples, Naples, Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5298859</comments>
            <pubDate>Wed, 05 Oct 2011 05:47:35 +0100</pubDate>
            <guid isPermaLink="false">5298859</guid>        </item>
        <item>
            <title>Frederik Barkhof, Nick C. Fox, Antonio J. Bastos-Leite, Philip Scheltens (eds): Neuroimaging in Dementia</title>
            <link>http://www.medworm.com/index.php?rid=5298858&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu478452x4485p0x2%2F</link>
            <description>Content Type Journal ArticleCategory Book ReviewPages 1-2DOI 10.1007/s00259-011-1947-1Authors
		Luigi Mansi, Second University of Naples, Naples, ItalyFrancesca Coppola, Second University of Naples, Naples, Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5298858</comments>
            <pubDate>Wed, 05 Oct 2011 05:47:35 +0100</pubDate>
            <guid isPermaLink="false">5298858</guid>        </item>
        <item>
            <title>Tony Theobald (ed): Sampson’s textbook of radiopharmacy (4th edition)</title>
            <link>http://www.medworm.com/index.php?rid=5277235&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F53847k8018054965%2F</link>
            <description>Content Type Journal ArticleCategory Book ReviewPages 1-2DOI 10.1007/s00259-011-1944-4Authors
		Sergio Todde, University of Milano-Bicocca, Monza, ItalyPhilip Elsinga, UMCG Groningen, University of Groningen, Groningen, The Netherlands
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5277235</comments>
            <pubDate>Thu, 29 Sep 2011 06:07:01 +0100</pubDate>
            <guid isPermaLink="false">5277235</guid>        </item>
        <item>
            <title>Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma</title>
            <link>http://www.medworm.com/index.php?rid=5277236&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6627265l06235786%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In our osteosarcoma patient population, 18F-FDG PET/CT indices (either combined metabolic/volumetric or metabolic indices) determined after neoadjuvant chemotherapy
 were useful in predicting tumour responses. This held true after only one chemotherapy course.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-1936-4Authors
		Hyung Jun Im, Department of Nuclear Medicine, National Cancer Center, Goyang-si, Gyeonggi-do 410-769, KoreaTae Sung Kim, Department of Nuclear Medicine, National Cancer Center, Goyang-si, Gyeonggi-do 410-769, KoreaSeog-Yun Park, Department of Pathology, National Cancer Center, Goyang-si, Gyeonggi-do 410-769, KoreaHye Sook Min, Department of Pathology, National Cancer Center, Goyang-si, Gyeonggi-do 410-7...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5277236</comments>
            <pubDate>Wed, 28 Sep 2011 05:53:48 +0100</pubDate>
            <guid isPermaLink="false">5277236</guid>        </item>
        <item>
            <title>Myo-Myo: Yes, papa. Eating sugar? No, papa!</title>
            <link>http://www.medworm.com/index.php?rid=5277237&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv71550n6r7073762%2F</link>
            <description>Content Type Journal ArticleCategory Editorial CommentaryPages 1-4DOI 10.1007/s00259-011-1896-8Authors
		Jagat Narula, Mount Sinai Medical Center &amp; Memorial Sloan-Kettering Cancer Center, New York, NY, USAH. William Strauss, Mount Sinai Medical Center &amp; Memorial Sloan-Kettering Cancer Center, New York, NY, USA
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5277237</comments>
            <pubDate>Tue, 27 Sep 2011 05:47:55 +0100</pubDate>
            <guid isPermaLink="false">5277237</guid>        </item>
        <item>
            <title>18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation</title>
            <link>http://www.medworm.com/index.php?rid=5264267&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2372065528013t76%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;
 18F-FDG PET/CT scanning during chemotherapy-induced febrile neutropenia and increased CRP is able to detect localized foci of
 infection and inflammation despite the absence of circulating neutrophils. Besides its potential role in detecting CVC-related
 infection during febrile neutropenia, the high negative predictive value of 18F-FDG PET/CT is important for avoiding unnecessary diagnostic tests and therapy.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1939-1Authors
		Fidel J. Vos, Department of Internal Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The NetherlandsJ. Peter Donnelly, Department of Hematology, Radboud University Nijmegen Medical Centre, Nijmegen, The NetherlandsW...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5264267</comments>
            <pubDate>Sat, 24 Sep 2011 05:46:50 +0100</pubDate>
            <guid isPermaLink="false">5264267</guid>        </item>
        <item>
            <title>Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer</title>
            <link>http://www.medworm.com/index.php?rid=5253870&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpu65l42425727604%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Baseline metabolic tumor burdens at the level of whole-body tumor, primary tumor, nodal metastasis, and distant metastasis
 as measured with MTV and TLG on FDG PET are prognostic measures independent of clinical stage with low inter-observer variability
 and may be used to further stratify nonsurgical patients with NSCLC. This study also suggests MTV and TLG are better prognostic
 measures than SUVmax and SUVmean. These results will need to be validated in larger cohorts in a prospective study.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-12DOI 10.1007/s00259-011-1934-6Authors
		Shengri Liao, Department of Radiology, MC 2026, University of Chicago, Chicago, IL 60637, USABill C. Penney, Department of Radiology, MC 2026, University of Chicago, C...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5253870</comments>
            <pubDate>Fri, 23 Sep 2011 05:55:19 +0100</pubDate>
            <guid isPermaLink="false">5253870</guid>        </item>
        <item>
            <title>Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study</title>
            <link>http://www.medworm.com/index.php?rid=5253872&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F880h55x470538043%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In our NB population 18F-dopa PET/CT displayed higher overall accuracy than 123I-MIBG scintigraphy. Consequently, we suggest 18F-dopa PET/CT as a new opportunity for NB assessment.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-15DOI 10.1007/s00259-011-1938-2Authors
		Arnoldo Piccardo, Nuclear Medicine Unit, Galliera Hospital, Genoa, ItalyEgesta Lopci, Nuclear Medicine Unit, Sant’Orsola-Malpighi Hospital, Bologna, ItalyMassimo Conte, Medical and Pediatric Oncology Division, G. Gaslini Hospital, Genoa, ItalyAlberto Garaventa, Medical and Pediatric Oncology Division, G. Gaslini Hospital, Genoa, ItalyLuca Foppiani, Endocrinology, Galliera Hospital, Genoa, ItalyVania Altrinetti, Nuclear Medicine Unit, Galliera Hospital, Genoa, ItalyCristina Nanni,...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5253872</comments>
            <pubDate>Tue, 20 Sep 2011 05:51:00 +0100</pubDate>
            <guid isPermaLink="false">5253872</guid>        </item>
        <item>
            <title>The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy</title>
            <link>http://www.medworm.com/index.php?rid=5253871&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgu31062720413711%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our results suggest that tumour sequestration of 68Ga-DOTA-octreotate is a major factor leading to a sink effect that decreases activity concentration in healthy organs such as the kidney. However, body habitus and renal function also
 influence tissue biodistribution, in a synergistic fashion. Compared with a fixed-dose peptide receptor radionuclide therapy
 protocol, an adjusted-dose regimen tailored to tumour burden, body habitus and renal function may allow greater radiation
 dose to individual lesions without substantially adding to toxicity in normal tissues.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s00259-011-1937-3Authors
		Jean-Mathieu Beauregard, Centre for Cancer Imaging, Peter MacCallum Cancer Centre and University...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5253871</comments>
            <pubDate>Tue, 20 Sep 2011 05:51:00 +0100</pubDate>
            <guid isPermaLink="false">5253871</guid>        </item>
        <item>
            <title>[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy</title>
            <link>http://www.medworm.com/index.php?rid=5253873&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff10t47r178842gk0%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In clinical practice, [11C]choline PET/CT may not replace BS because of its lower sensitivity. However, for its high specificity, [11C]choline PET/CT positive findings may accurately predict the presence of BM. Equivocal findings are more frequent in BS than
 [11C]choline PET/CT.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-14DOI 10.1007/s00259-011-1920-zAuthors
		Maria Picchio, Nuclear Medicine Department, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, ItalyElena Giulia Spinapolice, Center for Molecular Bioimaging, University of Milano-Bicocca, Milan, ItalyFederico Fallanca, Nuclear Medicine Department, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, ItalyCinzia Crivellaro, Center for Molecular Bioimaging,...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5253873</comments>
            <pubDate>Tue, 20 Sep 2011 05:50:59 +0100</pubDate>
            <guid isPermaLink="false">5253873</guid>        </item>
        <item>
            <title>Imaging the islet graft by positron emission tomography</title>
            <link>http://www.medworm.com/index.php?rid=5253874&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7522005708nl55u8%2F</link>
            <description>This article reviews the approaches available for islet graft imaging by positron emission tomography
 and progress in the field, as well as future challenges and opportunities.
 
 
	Content Type Journal ArticleCategory Review ArticlePages 1-10DOI 10.1007/s00259-011-1928-4Authors
		Olof Eriksson, Preclinical PET Platform, Department of Medicinal Chemistry, Uppsala University, SE-751 87 Uppsala, SwedenAbass Alavi, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5253874</comments>
            <pubDate>Tue, 20 Sep 2011 05:50:58 +0100</pubDate>
            <guid isPermaLink="false">5253874</guid>        </item>
        <item>
            <title>Early evaluation of the response of axillary lymph node metastases to neoadjuvant therapy: response to Gilardi et al.</title>
            <link>http://www.medworm.com/index.php?rid=5253875&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn3nhg63200554334%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s00259-011-1924-8Authors
		Caroline Rousseau, Nuclear Medicine Department, Comprehensive Cancer Center ICO Gauducheau, IRCNA, Saint Herblain, France
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5253875</comments>
            <pubDate>Tue, 20 Sep 2011 05:50:57 +0100</pubDate>
            <guid isPermaLink="false">5253875</guid>        </item>
        <item>
            <title>Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours</title>
            <link>http://www.medworm.com/index.php?rid=5241698&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2566p72523t63vg5%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;
 68Ga-DOTATOC PET/CT was considerably cheaper than 111In-DTPA-octreotide with respect to both material and personnel costs. Furthermore, by using 68Ga-DOTATOC PET/CT considerably fewer additional examinations were needed reducing the consequential costs significantly.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-1935-5Authors
		Nils F. Schreiter, Department of Nuclear Medicine, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyWinfried Brenner, Department of Nuclear Medicine, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyMunenobu Nogami, Department of Radiology and Nuclear Medicine, University Hospital, Kohasu, Oko-cho, Nankoku, Kochi, 783-8...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5241698</comments>
            <pubDate>Sat, 17 Sep 2011 05:43:14 +0100</pubDate>
            <guid isPermaLink="false">5241698</guid>        </item>
        <item>
            <title>Measurement of differential renal function in the presence of a pelvic kidney</title>
            <link>http://www.medworm.com/index.php?rid=5241699&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhq1727357j02v162%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-1DOI 10.1007/s00259-011-1927-5Authors
		Aditya Ham, Department of Nuclear Medicine, UZ Gent, Ghent, BelgiumAndre Dobbeleir, Department of Nuclear Medicine, UZ Gent, Ghent, Belgium
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5241699</comments>
            <pubDate>Sat, 17 Sep 2011 05:43:13 +0100</pubDate>
            <guid isPermaLink="false">5241699</guid>        </item>
        <item>
            <title>PET imaging of HER-2-positive tumours</title>
            <link>http://www.medworm.com/index.php?rid=5241700&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg421u61223146798%2F</link>
            <description>Content Type Journal ArticleCategory Editorial CommentaryPages 1-3DOI 10.1007/s00259-011-1933-7Authors
		Laura Gilardi, Division of Nuclear Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, ItalyGiovanni Paganelli, Division of Nuclear Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5241700</comments>
            <pubDate>Sat, 17 Sep 2011 05:43:10 +0100</pubDate>
            <guid isPermaLink="false">5241700</guid>        </item>
        <item>
            <title>Functional testicular evaluation using PET/CT with 18F-fluorodeoxyglucose</title>
            <link>http://www.medworm.com/index.php?rid=5213263&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9730278821138261%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This is the first report on the andrological value of FDG PET/CT in analysing nontumoral testicular function. This pilot study
 showed a significant correlation between intensity of uptake of FDG and testicular FV with the main sperm parameters. PET/CT
 with FDG could become a useful new tool in assisted reproductive technologies and other andrological or urological applications.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1929-3Authors
		Lawrence Oliver Dierickx, Service of Nuclear Medicine, Institut Claudius Regaud, 20-24, rue du Pont St Pierre, 31052 Toulouse, FranceEric Huyghe, CHU Toulouse, Toulouse, FranceDaniela Nogueira, I.F.R.E.A.R.E.S., Toulouse, FranceSlimane Zerdoud, Service of Nuclear Medicine, Institut Cl...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5213263</comments>
            <pubDate>Sat, 10 Sep 2011 05:45:17 +0100</pubDate>
            <guid isPermaLink="false">5213263</guid>        </item>
        <item>
            <title>Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105</title>
            <link>http://www.medworm.com/index.php?rid=5213264&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg933411718240355%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;We report here the first successful PET imaging of CD105 expression with 89Zr as the radiolabel. Rapid, persistent, CD105-specific uptake of 89Zr-Df-TRC105 in the 4T1 tumor was observed.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-1930-xAuthors
		Hao Hong, Department of Radiology, University of Wisconsin - Madison, Madison, WI, USAGregory W. Severin, Department of Medical Physics, University of Wisconsin - Madison, Madison, WI, USAYunan Yang, Department of Radiology, University of Wisconsin - Madison, Madison, WI, USAJonathan W. Engle, Department of Medical Physics, University of Wisconsin - Madison, Madison, WI, USAYin Zhang, Department of Medical Physics, University of Wisconsin - Madison, Madison, WI, USATodd E. Ba...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5213264</comments>
            <pubDate>Sat, 10 Sep 2011 05:45:16 +0100</pubDate>
            <guid isPermaLink="false">5213264</guid>        </item>
        <item>
            <title>Do we have to withdraw antiandrogenic therapy in prostate cancer patients before PET/CT with [11C]choline?</title>
            <link>http://www.medworm.com/index.php?rid=5213265&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4813n782g8q87477%2F</link>
            <description>Content Type Journal ArticleCategory Editorial CommentaryPages 1-3DOI 10.1007/s00259-011-1926-6Authors
		Giampiero Giovacchini, Department of Radiology and Nuclear Medicine, Division of Endocrine Diagnostics and Radionuclide Therapy, Basel University Hospital, Petersgrabenstrasse, 4, 4031 Basel, Switzerland
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5213265</comments>
            <pubDate>Thu, 08 Sep 2011 05:53:14 +0100</pubDate>
            <guid isPermaLink="false">5213265</guid>        </item>
        <item>
            <title>Septic pulmonary embolisms and metastatic infections from methicillin-resistant Staphylococcus aureus endocarditis on FDG PET/CT</title>
            <link>http://www.medworm.com/index.php?rid=5213268&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa7260223484xh125%2F</link>
            <description>Content Type Journal ArticleCategory Image of the monthPages 1-1DOI 10.1007/s00259-011-1932-8Authors
		Olivier Gheysens, Department of Nuclear Medicine, University Hospital Leuven, Leuven, BelgiumNele Lips, Department of Nuclear Medicine, University Hospital Leuven, Leuven, BelgiumTom Adriaenssens, Department of Cardiovascular Diseases, University Hospital Leuven, Leuven, BelgiumSteven Pans, Department of Radiology, University Hospital Leuven, Leuven, BelgiumJohan Maertens, Department of Hematology, University Hospital Leuven, Leuven, BelgiumMarie-Christine Herregods, Department of Cardiovascular Diseases, University Hospital Leuven, Leuven, BelgiumPaul Herijgers, Department of Cardiovascular Diseases, University Hospital Leuven, Leuven, BelgiumWilly E. Peetermans, Department of General ...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5213268</comments>
            <pubDate>Thu, 08 Sep 2011 05:53:13 +0100</pubDate>
            <guid isPermaLink="false">5213268</guid>        </item>
        <item>
            <title>Are we ready for an early evaluation of the response of axillary lymph node metastases to neoadjuvant therapy?</title>
            <link>http://www.medworm.com/index.php?rid=5213267&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj87m877j8268u012%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s00259-011-1921-yAuthors
		Laura Gilardi, Division of Nuclear Medicine, European Institute of Oncology, Milan, ItalyConcetta De Cicco, Division of Nuclear Medicine, European Institute of Oncology, Milan, ItalyGiovanni Paganelli, Division of Nuclear Medicine, European Institute of Oncology, Milan, Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5213267</comments>
            <pubDate>Thu, 08 Sep 2011 05:53:13 +0100</pubDate>
            <guid isPermaLink="false">5213267</guid>        </item>
        <item>
            <title>Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective</title>
            <link>http://www.medworm.com/index.php?rid=5213266&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft63r422455n61q12%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Despite preclinical promise, the progress of cell-based therapy to clinical cardiovascular practice has been slowed by several
 challenges and uncertainties that have been highlighted by the conflicting results of human trials. Most telling has been
 the revelation that current strategies fall short of achieving sufficient retention and engraftment of cells to meet the ambitious
 objective of myocardial regeneration. This has sparked novel research into the refinement of cell biology and delivery to
 overcome these shortcomings. Within this context, molecular imaging has emerged as a valuable tool for providing noninvasive
 surveillance of cell fate in vivo. Direct and indirect labelling of cells can be coupled with clinically relevant imaging
 modalities, such as radio...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5213266</comments>
            <pubDate>Thu, 08 Sep 2011 05:53:13 +0100</pubDate>
            <guid isPermaLink="false">5213266</guid>        </item>
        <item>
            <title>Activity quantification combining conjugate-view planar scintigraphies and SPECT/CT data for patient-specific 3-D dosimetry in radionuclide therapy</title>
            <link>http://www.medworm.com/index.php?rid=5213269&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2222614w15332682%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The proposed activity quantification method for 2-D scintigraphies can speed up SPECT/CT-based 3-D dosimetry without losing
 accuracy.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-13DOI 10.1007/s00259-011-1889-7Authors
		Yannick Berker, Department of Experimental Molecular Imaging, RWTH Aachen University Hospital, Pauwelsstraße 30, 52074 Aachen, GermanyAndreas Goedicke, Philips Technologie GmbH Innovative Technologies, Research Laboratories, Weißhausstraße 2, 52066 Aachen, GermanyGerrit J. Kemerink, Department of Nuclear Medicine, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, The NetherlandsTil Aach, Institute of Imaging &amp; Computer Vision, RWTH Aachen University, Templergraben 55, 52056 Aachen, GermanyBernd Schw...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5213269</comments>
            <pubDate>Thu, 08 Sep 2011 05:53:12 +0100</pubDate>
            <guid isPermaLink="false">5213269</guid>        </item>
        <item>
            <title>Myocardial perfusion scintigraphy in Europe 2007: a survey of the European Council of Nuclear Cardiology</title>
            <link>http://www.medworm.com/index.php?rid=5198982&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa28842561g1lq675%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;MPS utilization in Europe remains low compared with coronary angiography although there has been a 21% increase in the number
 of studies pmp in centres that reported in both 2005 and 2007. Pharmacological agents continue to be the predominant form
 of stress. Despite the widespread use of technetium-99m-labelled tracers, ECG gating is not universally performed. As in the
 2005 survey, imaging aids such as attenuation and motion correction and prone imaging are not commonly used.
 
 
 
 
	Content Type Journal ArticleCategory Occasional SurveyPages 1-5DOI 10.1007/s00259-011-1923-9Authors
		Eliana Reyes, Nuclear Medicine Department, Royal Brompton Hospital, Sydney Street, SW3 6NP London, UKSusanna Wiener, European Council of Nuclear Cardiology, Hollandstrasse 14 / Mezza...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5198982</comments>
            <pubDate>Mon, 05 Sep 2011 16:16:30 +0100</pubDate>
            <guid isPermaLink="false">5198982</guid>        </item>
        <item>
            <title>Voriconazole-induced periostitis</title>
            <link>http://www.medworm.com/index.php?rid=5198981&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj74716v481405m52%2F</link>
            <description>Content Type Journal ArticleCategory Image of the MonthPages 1-2DOI 10.1007/s00259-011-1922-xAuthors
		Christine Rossier, Department of Nuclear Medicine, CHUV and University of Lausanne, Lausanne, SwitzerlandVincent Dunet, Department of Nuclear Medicine, CHUV and University of Lausanne, Lausanne, SwitzerlandFrederic Tissot, Department of Medicine, Infectious Diseases Service, CHUV and University of Lausanne, Lausanne, SwitzerlandBerengère Aubry-Rozier, Center of Bone Diseases, CHUV and University of Lausanne, Lausanne, SwitzerlandOlivier Marchetti, Department of Medicine, Infectious Diseases Service, CHUV and University of Lausanne, Lausanne, SwitzerlandAriane Boubaker, Department of Nuclear Medicine, CHUV and University of Lausanne, Lausanne, Switzerland
	

	
		Journal European Journal...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5198981</comments>
            <pubDate>Mon, 05 Sep 2011 16:16:30 +0100</pubDate>
            <guid isPermaLink="false">5198981</guid>        </item>
        <item>
            <title>Early interim 18F-FDG PET in Hodgkin’s lymphoma: evaluation on 304 patients</title>
            <link>http://www.medworm.com/index.php?rid=5198983&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr05u7565nq738662%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our results demonstrate the role of an early PET scan as a significant step forward in the management of patients with early-stage
 or advanced-stage HL.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1916-8Authors
		Pier Luigi Zinzani, Institute of Hematology and Medical Oncology “L. e A. Seràgnoli”, Policlinico “Sant’Orsola-Malpighi”, University of Bologna, Bologna, ItalyLuigi Rigacci, Hematology Department, Azienda Ospedaliero Universitaria “Careggi”, Florence, ItalyVittorio Stefoni, Institute of Hematology and Medical Oncology “L. e A. Seràgnoli”, Policlinico “Sant’Orsola-Malpighi”, University of Bologna, Bologna, ItalyAlessandro Broccoli, Institute of Hematology and Medical Oncology “L. e ...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5198983</comments>
            <pubDate>Mon, 05 Sep 2011 16:16:28 +0100</pubDate>
            <guid isPermaLink="false">5198983</guid>        </item>
        <item>
            <title>Quantification of receptor-ligand binding with [18F]fluciclatide in metastatic breast cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=5198984&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F279u350272065222%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Besides establishing the best quantitative approaches for the analysis of [18F]fluciclatide data, this study indicated that the k3/k4 ratio is a reasonable measure of specific binding, suggesting that this index can be used to estimate αvβ3/5 receptor expression in oncology, although further studies are necessary to validate this hypothesis.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-12DOI 10.1007/s00259-011-1907-9Authors
		Giampaolo Tomasi, Comprehensive Cancer Imaging Center, Imperial College, Hammersmith Hospital, Du Cane Road, London, W12 0NN UKLaura Kenny, Comprehensive Cancer Imaging Center, Imperial College, Hammersmith Hospital, Du Cane Road, London, W12 0NN UKFrancesco Mauri, Department of Medicine, Imperial College, Hammersmith H...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5198984</comments>
            <pubDate>Sat, 03 Sep 2011 06:39:52 +0100</pubDate>
            <guid isPermaLink="false">5198984</guid>        </item>
        <item>
            <title>Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study</title>
            <link>http://www.medworm.com/index.php?rid=5198985&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F16238043173566k7%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;
 177Lu-DOTATATE was well tolerated up to 29&amp;nbsp;GBq cumulative activity (up to 7.4&amp;nbsp;GBq/cycle). The maximum tolerated dose/cycle was
 not reached. However, considering the individual bone marrow function and the presence of risk factors for kidney toxicity,
 it seems safer to divide cumulative activities into lower activity cycles.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s00259-011-1902-1Authors
		Lisa Bodei, Division of Nuclear Medicine, European Institute of Oncology, Via Ripamonti, 435-20141 Milan, ItalyMarta Cremonesi, Division of Medical Physics, European Institute of Oncology, Milan, ItalyChiara M. Grana, Division of Nuclear Medicine, European Institute of Oncology, Via Ripamonti, 435-20141 Milan, ItalyNicola Faz...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5198985</comments>
            <pubDate>Sat, 03 Sep 2011 06:39:51 +0100</pubDate>
            <guid isPermaLink="false">5198985</guid>        </item>
        <item>
            <title>High diagnostic accuracy of low-dose gated-SPECT with solid-state ultrafast detectors: preliminary clinical results</title>
            <link>http://www.medworm.com/index.php?rid=5193136&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8034541326183450%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This pilot study demonstrated the feasibility of a low-dose single-day stress–rest fasting protocol performed using UF SPECT,
 with good sensitivity and specificity in detecting CAD at low patient exposure, opening new perspectives in the use of myocardial
 perfusion in ischaemic patients.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00259-011-1918-6Authors
		Alessia Gimelli, Fondazione Toscana Gabriele Monasterio, CNR, Via Moruzzi, 1, 56124 Pisa, ItalyMatteo Bottai, Division of Biostatistics, University of South Carolina, Columbia, SC, USADario Genovesi, Fondazione Toscana Gabriele Monasterio, CNR, Via Moruzzi, 1, 56124 Pisa, ItalyAssuero Giorgetti, Fondazione Toscana Gabriele Monasterio, CNR, Via Moruzzi, 1, 56124 Pisa, Italy...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5193136</comments>
            <pubDate>Fri, 02 Sep 2011 05:51:23 +0100</pubDate>
            <guid isPermaLink="false">5193136</guid>        </item>
        <item>
            <title>Validation of Tikhonov adaptively regularized gamma variate fitting with 24-h plasma clearance in cirrhotic patients with ascites</title>
            <link>http://www.medworm.com/index.php?rid=5187032&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw11377l3j0465u74%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;
 CL(E1) values were dependent on sample time and the quality of fit was poor and degraded with increasing ascites, consistent
 with current opinion that CL(E1) is contraindicated in ascitic patients. CL(Tk-GV) was relatively more accurate and the good quality of fit was unaffected by ascites. CL(Tk-GV) was the preferred method for the accurate calculation of CL and was useful despite liver failure and ascites.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-10DOI 10.1007/s00259-011-1887-9Authors
		Carl Adam Wesolowski, Radiology, Memorial University of Newfoundland, St. John’s, NL, CanadaLin Ling, Radiology, Memorial University of Newfoundland, St. John’s, NL, CanadaElias Xirouchakis, The Royal Free Sheila Sherlock Liver Centre, Royal Free H...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5187032</comments>
            <pubDate>Wed, 31 Aug 2011 15:53:39 +0100</pubDate>
            <guid isPermaLink="false">5187032</guid>        </item>
        <item>
            <title>Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine – a review</title>
            <link>http://www.medworm.com/index.php?rid=5187034&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj50177h5p8183p4v%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;It would be of interest to generate new data on biokinetics and dosimetry in diagnostic nuclear medicine using state-of-the-art
 equipment and more uniform dosimetry protocols. For easier public access to dosimetry data for diagnostic radiopharmaceuticals,
 a database containing these data should be created and maintained.
 
 
 
 
	Content Type Journal ArticleCategory Review ArticlePages 1-13DOI 10.1007/s00259-011-1904-zAuthors
		Uta Eberlein, Department of Nuclear Medicine, University of Würzburg, Oberdürrbacher Str. 6, 97080 Würzburg, GermanyJörn Hendrik Bröer, Department of Radiation Protection and Health, Federal Office for Radiation Protection, Oberschleißheim, GermanyCharlot Vandevoorde, Department of Basic Medical Sciences, Division of Medical Physics, Gh...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5187034</comments>
            <pubDate>Mon, 29 Aug 2011 15:59:09 +0100</pubDate>
            <guid isPermaLink="false">5187034</guid>        </item>
        <item>
            <title>The 50th Anniversary of Nuclear Medicine in Innsbruck</title>
            <link>http://www.medworm.com/index.php?rid=5187033&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb36081842242l082%2F</link>
            <description>Content Type Journal ArticleCategory Society CommunicationsPages 1-1DOI 10.1007/s00259-011-1897-7

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5187033</comments>
            <pubDate>Mon, 29 Aug 2011 15:59:09 +0100</pubDate>
            <guid isPermaLink="false">5187033</guid>        </item>
        <item>
            <title>The importance of correction for tissue fraction effects in lung PET: preliminary findings</title>
            <link>http://www.medworm.com/index.php?rid=5171835&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5474565882807131%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp; The proposed tissue fraction correction method is a promising technique to account for variability of density in interpreting
 lung PET studies.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1906-xAuthors
		Tryphon Lambrou, Institute of Nuclear Medicine, University College London, 235 Euston Road (T5), London, NW1 2BU UKAshley M. Groves, Institute of Nuclear Medicine, University College London, 235 Euston Road (T5), London, NW1 2BU UKKjell Erlandsson, Institute of Nuclear Medicine, University College London, 235 Euston Road (T5), London, NW1 2BU UKNick Screaton, Radiology, Papworth Hospital, Papworth Everard, Cambridge, CB3 8RE UKRaymondo Endozo, Institute of Nuclear Medicine, University College London, 235 Euston Road ...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5171835</comments>
            <pubDate>Fri, 26 Aug 2011 16:16:40 +0100</pubDate>
            <guid isPermaLink="false">5171835</guid>        </item>
        <item>
            <title>Differential diagnosis of solitary pulmonary nodules using 99mTc-3P4-RGD2 scintigraphy</title>
            <link>http://www.medworm.com/index.php?rid=5171836&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4w702294882784v5%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In this first-in-human study, we demonstrated the feasibility of using 99mTc-3P4-RGD2 scintigraphy in differentiating SPNs. This procedure appears to be highly sensitive in detection of malignant SPNs. SPECT
 visual analysis seems to be sufficient for characterization of SPNs.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00259-011-1901-2Authors
		Qingjie Ma, Department of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, 130033 ChinaBin Ji, Department of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, 130033 ChinaBing Jia, Medical Isotopes Research Center, Peking University, Beijing, 100191 ChinaShi Gao, Department of Nuclear Medicine, China-Japan Union Hospital of Jilin Uni...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5171836</comments>
            <pubDate>Fri, 26 Aug 2011 16:16:38 +0100</pubDate>
            <guid isPermaLink="false">5171836</guid>        </item>
        <item>
            <title>Statistical parametric maps of 18F-FDG PET and 3-D autoradiography in the rat brain: a cross-validation study</title>
            <link>http://www.medworm.com/index.php?rid=5171838&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft315l62464306q02%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This study demonstrates that any difference detected with SPM analysis of MOSAIC PET images of rat brain is detected also
 by the gold standard autoradiographic technique, confirming that this methodology provides reliable results, although partial
 volume effects might make it difficult to detect slight differences in small regions.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-10DOI 10.1007/s00259-011-1905-yAuthors
		Elena Prieto, Nuclear Medicine Department, Clínica Universidad de Navarra, Av. Pío XII 36, 31008 Pamplona, SpainMaría Collantes, Small Animal Imaging Research Unit, Center for Applied Medical Research (CIMA) and Clínica Universidad de Navarra, Pamplona, SpainMercedes Delgado, Brain Mapping Unit, Universidad Complutense de Mad...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5171838</comments>
            <pubDate>Fri, 26 Aug 2011 16:16:37 +0100</pubDate>
            <guid isPermaLink="false">5171838</guid>        </item>
        <item>
            <title>Attenuation correction for myocardial perfusion SPECT imaging: still a controversial issue</title>
            <link>http://www.medworm.com/index.php?rid=5171837&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3118137132m05206%2F</link>
            <description>Content Type Journal ArticleCategory Editorial CommentaryPages 1-3DOI 10.1007/s00259-011-1898-6Authors
		Alberto Cuocolo, Department of Biomorphological and Functional Sciences, University Federico II, Naples, Italy
	

	
		Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5171837</comments>
            <pubDate>Fri, 26 Aug 2011 16:16:37 +0100</pubDate>
            <guid isPermaLink="false">5171837</guid>        </item>
        <item>
            <title>Impact of [18F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology</title>
            <link>http://www.medworm.com/index.php?rid=5150012&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw757487117460343%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The accuracy and precision of all studied tumour delineation methods was affected by physiological and imaging parameters.
 The latter illustrates the need for optimizing imaging parameters and/or for careful calibration and optimization of delineation
 methods.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1899-5Authors
		Patsuree Cheebsumon, Department of Nuclear Medicine &amp; PET Research, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The NetherlandsMaqsood Yaqub, Department of Nuclear Medicine &amp; PET Research, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The NetherlandsFloris H. P. van Velden, Department of Nuclear Medicine &amp; PET Research, VU University Medical Center, P.O. Box 7057, ...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5150012</comments>
            <pubDate>Fri, 19 Aug 2011 15:52:59 +0100</pubDate>
            <guid isPermaLink="false">5150012</guid>        </item>
        <item>
            <title>Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide</title>
            <link>http://www.medworm.com/index.php?rid=5150011&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnu7g23m15kw75222%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Pretargeting achieves high tumor uptake and higher tumor to background ratios compared to direct RIT. Short-lived radionuclides
 are predicted to deliver high tumor absorbed doses especially 211At, with kidneys being the dose-limiting organ. 177Lu and 131I should be considered for repeated injections.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-12DOI 10.1007/s00259-011-1903-0Authors
		Eric Frampas, Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Université de Nantes, Inserm, UMR 892, 8 quai Moncousu, BP 70721, 44007 Nantes cedex 1, FranceCatherine Maurel, Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Université de Nantes, Inserm, UMR 892, 8 quai Moncousu, BP 70721, 44007 Nantes cedex 1, FrancePatricia Remaud-Le Sa...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5150011</comments>
            <pubDate>Fri, 19 Aug 2011 15:52:59 +0100</pubDate>
            <guid isPermaLink="false">5150011</guid>        </item>
        <item>
            <title>Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=5150014&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq63451m81586r405%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The overall diagnostic performance of post-treatment FDG PET(CT) for response assessment and surveillance imaging of HNSCC
 is good, but its PPV is somewhat suboptimal. Its NPV remains exceptionally high and a negative post-treatment scan is highly
 suggestive of absence of viable disease that can guide therapeutic decision-making. Timing of post-treatment imaging has a
 significant, though moderate impact on diagnostic accuracy.
 
 
 
 
	Content Type Journal ArticleCategory Review ArticlePages 1-13DOI 10.1007/s00259-011-1893-yAuthors
		Tejpal Gupta, Department of Radiation Oncology, Tata Memorial Centre, Kharghar, Navi Mumbai, IndiaZubin Master, Department of Radiation Oncology, Tata Memorial Centre, Kharghar, Navi Mumbai, IndiaSadhana Kannan, Epidemiology Clinical T...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5150014</comments>
            <pubDate>Fri, 19 Aug 2011 06:40:19 +0100</pubDate>
            <guid isPermaLink="false">5150014</guid>        </item>
        <item>
            <title>In vivo imaging of astrocytosis in Alzheimer’s disease: an 11C-L-deuteriodeprenyl and PIB PET study</title>
            <link>http://www.medworm.com/index.php?rid=5150013&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F141827584515p802%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our conclusion is that DED may serve as an in vivo marker for astrocytosis in AD, providing a window into intermediate processes
 between amyloidosis and neuronal loss and a means of monitoring immunotherapy.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s00259-011-1895-9Authors
		Alexander Frizell Santillo, Geriatric Psychiatry, Department of Clinical Medicine, Lund University, c/o Cognitive Medicine, University Hospital, 221 85 Lund, SwedenJuan Pablo Gambini, Faculty of Medicine and Faculty of Science, University of the Republic, Montevideo, UruguayLars Lannfelt, Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Uppsala Science Park, 751 85 Uppsala, SwedenBengt Långström, Departments of Biochemistr...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5150013</comments>
            <pubDate>Fri, 19 Aug 2011 06:40:19 +0100</pubDate>
            <guid isPermaLink="false">5150013</guid>        </item>
        <item>
            <title>Relationship between vascular stiffness and stress myocardial perfusion imaging in asymptomatic patients with diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5150015&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx263818158l20716%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Vascular stiffness measured by PWV is associated with severe MPI defects in asymptomatic patients with diabetes.
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00259-011-1894-xAuthors
		Cornelis J. Roos, Department of Cardiology, C5-P, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The NetherlandsRoxana Djaberi, Department of Cardiology, C5-P, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The NetherlandsJoanne D. Schuijf, Department of Cardiology, C5-P, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The NetherlandsEelco J. de Koning, Department of Nephrology, Leiden University Medical Center, Leiden, The NetherlandsTon J. Rabelink, Department of Nephrology, Leiden University Medical...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5150015</comments>
            <pubDate>Thu, 18 Aug 2011 06:01:15 +0100</pubDate>
            <guid isPermaLink="false">5150015</guid>        </item>
        <item>
            <title>Left ventricular diastolic dyssynchrony assessed with phase analysis of gated myocardial perfusion SPECT: a comparison with tissue Doppler imaging</title>
            <link>http://www.medworm.com/index.php?rid=5150017&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd8p6657342661613%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Phase analysis on GMPS showed good correlations with TDI for the assessment of LV diastolic dyssynchrony.
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00259-011-1870-5Authors
		Mark J. Boogers, Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA The NetherlandsJi Chen, Department of Radiology, Emory University School of Medicine, Atlanta, GA, USACaroline E. Veltman, Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA The NetherlandsRutger J. van Bommel, Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA The NetherlandsEline A. Q. Mooyaart, Department of Cardiology, Leiden University Medical Center, Albinusdreef 2...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5150017</comments>
            <pubDate>Thu, 18 Aug 2011 06:01:14 +0100</pubDate>
            <guid isPermaLink="false">5150017</guid>        </item>
        <item>
            <title>Reduction of artefacts caused by hip implants in CT-based attenuation-corrected PET images using 2-D interpolation of a virtual sinogram on an irregular grid</title>
            <link>http://www.medworm.com/index.php?rid=5150016&amp;cid=s_33422_37_f&amp;fid=33422&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm52580318799k4v4%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The proposed MAR method allows more accurate CT-based attenuation correction of PET images and prevents misinterpretation
 of tracer uptake, which might be biased owing to the propagation of bright and dark streaking artefacts from CT images to
 the PET data following the attenuation correction procedure.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-12DOI 10.1007/s00259-011-1900-3Authors
		Mehrsima Abdoli, Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The NetherlandsJohan R. de Jong, Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The NetherlandsJan Pruim, Department of ...</description>
            <author>European Journal of Nuclear Medicine and Molecular Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5150016</comments>
            <pubDate>Thu, 18 Aug 2011 06:01:14 +0100</pubDate>
            <guid isPermaLink="false">5150016</guid>        </item>
    </channel>
</rss>

